{"study_id": 113910, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were examining obesity as a risk factor for COVID-19 susceptibility and severity, not directly evaluating bariatric surgery.", "results_summary": "The abstract does not provide results related to bariatric surgery; it focuses on obesity as a risk factor for COVID-19.", "population_specificity": "Individuals with obesity, particularly severe obesity (BMI > 40 kg/m\u00b2).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:30.331174+00:00"}
{"study_id": 113909, "supplement_id": 913, "safety_score": "60", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review emergent data on sleeve gastrectomy and bone loss, evidence linking bariatric surgery to fracture risk, and intervention strategies to mitigate surgical bone loss.", "results_summary": "The study highlights adverse skeletal health outcomes post-bariatric surgery, including bone loss and increased fracture risk, while also discussing potential intervention strategies to address these issues.", "population_specificity": "Patients planning or undergoing bariatric surgery.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:31.042731+00:00"}
{"study_id": 113908, "supplement_id": 913, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to summarize the benefits and risks of bariatric surgery to guide shared decision-making for patients with severe obesity and related conditions like type 2 diabetes.", "results_summary": "Bariatric surgery results in greater improvements in weight loss and type 2 diabetes outcomes compared to nonsurgical interventions, with similar safety profiles for sleeve gastrectomy and gastric bypass. Perioperative mortality rates are low (0.03% to 0.2%), and emerging evidence suggests sleeve gastrectomy has fewer reoperations, while gastric bypass may offer more durable weight loss and glycemic control.", "population_specificity": "Patients with severe obesity (BMI \u226540 or \u226535 with comorbidities) and those with type 2 diabetes (BMI 30-35 with uncontrolled hyperglycemia).", "effective_dosage": "Not Assessed", "study_duration": "At least 5-year follow-up for safety and efficacy comparisons.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:32.808372+00:00"}
{"study_id": 113912, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the impact of sleeve gastrectomy-induced weight loss on ventilatory function at rest and during exercise in patients with severe obesity.", "results_summary": "The study found significant weight loss (26.35% of body weight) post-surgery, leading to reduced restrictive respiratory limitations and improved ventilatory efficiency at rest and during exercise.", "population_specificity": "46 patients with severe obesity (76% females).", "effective_dosage": "Not applicable (surgical intervention).", "study_duration": "6 months post-surgery.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:34.316430+00:00"}
{"study_id": 113913, "supplement_id": 913, "safety_score": "70", "efficacy_score": 80, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the effects of bariatric surgery on weight loss, glucose metabolism, lipid levels, blood pressure, and quality of life in obese patients, as well as assess nutritional deficiencies post-surgery.", "results_summary": "Bariatric surgery significantly improved weight, glucose levels, islet function, blood pressure, and lipid profiles within the first 6 months to 1 year, though some rebound occurred by 3 years. Nutritional deficiencies (e.g., vitamin D, calcium, iron) were common post-surgery, but quality of life improved compared to controls.", "population_specificity": "20 obese patients in China who underwent bariatric surgery and completed follow-ups.", "effective_dosage": "Not specified", "study_duration": "3-year follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:35.737871+00:00"}
{"study_id": 113911, "supplement_id": 913, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the incidence of internal herniation (IH) after robot-assisted Roux-en-Y gastric bypass (RA-RYGB) using the \"Double Loop\" technique.", "results_summary": "The study found a low complication rate and no cases of internal herniation in patients who underwent RA-RYGB with the \"Double Loop\" technique, suggesting its safety and efficacy at a medium-term follow-up. The results were consistent across both primary and revisional procedures.", "population_specificity": "129 patients (50.4% primary procedures, 49.6% revisional operations after restrictive bariatric surgery) with a mean age of 47.9 years and mean BMI of 39.7 kg/m\u00b2.", "effective_dosage": "Not Assessed", "study_duration": "Minimum follow-up of 2 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:36.582965+00:00"}
{"study_id": 113914, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess whether baseline clinical characteristics of patients undergoing sleeve gastrectomy or gastric bypass were associated with unsuccessful weight loss after 12 and 24 months.", "results_summary": "Older age, larger neck circumference, and lower %EWL at 6 months were significantly associated with unsuccessful weight loss after surgery, with nearly 90% of these patients showing early failure. Age and %EWL at 6 months were predictive of poor outcomes at both 12 and 24 months, while neck circumference was specifically linked to 24-month failure.", "population_specificity": "300 patients with morbid obesity who underwent bariatric surgery (sleeve gastrectomy or gastric bypass) with at least 24 months of follow-up.", "effective_dosage": "Not specified", "study_duration": "24 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:38.132572+00:00"}
{"study_id": 113917, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to discuss the implications of NAFLD for surgery, including bariatric surgery, and the challenges in patient management.", "results_summary": "Bariatric surgery showed favorable results for weight loss and managing NAFLD-related conditions like HCC and ESLD, but the abstract does not provide detailed outcome metrics.", "population_specificity": "Patients with NAFLD, particularly those with metabolic comorbidities, end-stage liver disease, or hepatocellular carcinoma.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:38.266563+00:00"}
{"study_id": 113915, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of fecal microbiota changes in mediating weight loss and metabolic benefits following bariatric surgery (LSG and RYGB).", "results_summary": "The study found that LSG and RYGB induce procedure-specific changes in fecal microbiota, which may contribute to weight loss and metabolic improvements. Rodent studies suggest the gut microbiome influences immunological, inflammatory, and metabolic pathways, highlighting its potential as a therapeutic target.", "population_specificity": "Obesity patients undergoing bariatric surgery (LSG or RYGB).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:38.468322+00:00"}
{"study_id": 113919, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to examine the usefulness of the Edmonton Obesity Staging System (EOSS) for stratifying weight-related health problems, particularly in predicting risks and benefits of bariatric surgery.", "results_summary": "The EOSS was consistently associated with increased postoperative complications (especially for EOSS 3-4) and inversely associated with weight loss, treatment time, and resolution of hypertension following bariatric surgery. It also predicted mortality outcomes and poorer work outcomes in community populations.", "population_specificity": "Participants with overweight or obesity in clinical and community settings.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:39.587168+00:00"}
{"study_id": 113920, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to review the therapeutic options for childhood obesity, including the role of bariatric surgery in selected cases.", "results_summary": "The abstract mentions bariatric surgery as a potential treatment strategy for selected cases of childhood obesity, alongside multidisciplinary approaches, but does not provide specific efficacy data.", "population_specificity": "Children with obesity (selected cases).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:40.394190+00:00"}
{"study_id": 113921, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the association between bariatric surgery and all-cause mortality, including cause-specific mortality, in a matched cohort.", "results_summary": "Bariatric surgery was associated with substantially lower all-cause, cardiovascular, and cancer mortality, with significant effects across most subgroups, particularly in men and patients aged 55 or older. The overall mortality rate was 1.4% after a median follow-up of 4.9 years.", "population_specificity": "13,679 patients who underwent bariatric surgery in Ontario, Canada, from 2010 to 2016, matched to 13,679 nonsurgical patients by age, sex, BMI, and diabetes duration.", "effective_dosage": "Not specified", "study_duration": "Median follow-up of 4.9 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:43.877328+00:00"}
{"study_id": 113922, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "To determine the 3-year effects of Roux-en-Y gastric bypass (RYGB) on blood pressure compared with medical therapy alone in patients with obesity and hypertension.", "results_summary": "RYGB plus medical therapy resulted in a higher rate of hypertension remission and better BP control with fewer medications compared to medical therapy alone. The surgery was effective for midterm BP control and hypertension remission.", "population_specificity": "Patients with hypertension receiving at least 2 medications at maximum doses or more than 2 medications at moderate doses and with a BMI between 30.0 and 39.9 kg/m\u00b2.", "effective_dosage": "Not specified", "study_duration": "3 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:45.137646+00:00"}
{"study_id": 113925, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the effects of bariatric surgery on microbiota composition in humans and other vertebrates, evaluate the influence of probiotics on postoperative health, and explore interactions between microbiota and psychological/behavioral factors.", "results_summary": "The study found that bariatric surgery leads to changes in microbiota composition, including increased abundance of Proteobacteria, but changes in alpha diversity were not specific to the surgery. Probiotics' impact and microbiota-psychological interactions were also investigated.", "population_specificity": "Humans and other vertebrates (specific subgroups not detailed in the abstract).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:47.393607+00:00"}
{"study_id": 113924, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine the current evidence and guidelines regarding the impact of bariatric surgery on Barrett's esophagus (BE) development, progression, or regression, and its implications for esophageal adenocarcinoma (EAC) management.", "results_summary": "The study found that bariatric surgery significantly affects BE, with sleeve gastrectomy increasing gastroesophageal reflux and de novo BE risk, while Roux-en-Y gastric bypass may reduce reflux and improve or resolve BE. Current screening practices vary, and there are no established guidelines for BE surveillance post-surgery.", "population_specificity": "Patients with obesity, particularly those at risk for or diagnosed with Barrett's esophagus.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:47.460370+00:00"}
{"study_id": 113926, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate whether bariatric surgery reverses neurodegeneration of the optic nerve and impacts retinal and optic nerve structure in obese patients.", "results_summary": "The study found significant thickening of the retina after bariatric surgery, confined to inner retinal layers, suggesting improved perfusion, but no changes in the ganglion cell layer, choroid, or peripapillary nerve fiber layer thickness. Clinical predictors of retinal thickening included HbA1c variation, preoperative C-peptide, hypertension, OSA, and LDL/TG levels.", "population_specificity": "Obese patients scheduled for bariatric surgery (40 participants, 80 eyes).", "effective_dosage": "Not specified", "study_duration": "6-12 months post-surgery", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:47.869647+00:00"}
{"study_id": 113927, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of bariatric surgery in treating obesity, hypertension, type 2 diabetes, and its potential benefits in reducing chronic kidney disease (CKD) incidence and progression.", "results_summary": "The study found that bariatric surgery not only aids in weight reduction, blood pressure control, and metabolic improvements but also may reduce CKD incidence and progression. Preclinical studies supported these findings by demonstrating functional, structural, and transcriptomic improvements in kidney injury.", "population_specificity": "Patients with obesity, hypertension, type 2 diabetes, and chronic kidney disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:48.617225+00:00"}
{"study_id": 113928, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the reliability of non-invasive vascular unloading (Nexfin\u00ae) versus semi-invasive pulse contour analysis (FloTrac\u2122) for continuous cardiac index (CI) measurements in morbidly obese patients undergoing laparoscopic bariatric surgery.", "results_summary": "The study found that non-invasive CI measurements did not meet interchangeability criteria with semi-invasive methods for monitoring absolute and trending values of CI in bariatric surgery patients. The results were based on correlation, Bland-Altman, and concordance analyses across 10 measurement time points.", "population_specificity": "Adult morbidly obese patients (mean BMI 49.2 kg/m\u00b2) undergoing elective laparoscopic bariatric surgery.", "effective_dosage": "Not applicable (hemodynamic monitoring study).", "study_duration": "Perioperative period (pre- and intraoperative measurements).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:50.997828+00:00"}
{"study_id": 113929, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the effects of testosterone treatment (TTh) on markers of fat and liver functioning in obese men scheduled for bariatric surgery.", "results_summary": "TTh in hypogonadal men improved insulin sensitivity, mitochondrial function, and lipid handling in preadipocytes, and reduced NAFLD activity, steatosis scores, and liver triglyceride content compared to untreated hypogonadal men. These effects were comparable to those seen in eugonadal men.", "population_specificity": "Severely obese, hypogonadal men scheduled for bariatric surgery.", "effective_dosage": "Not specified", "study_duration": "27.63 \u00b1 3.64 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:52.507467+00:00"}
{"study_id": 113930, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to analyze the effects of surgical and nonsurgical weight loss on hepatocellular adenoma (HCA) regression in obese patients.", "results_summary": "The study found that effective long-term weight loss, both surgical and nonsurgical, resulted in regression of HCAs, potentially avoiding major liver resections or reducing morbidity. However, the analysis was limited to a small sample size of 7 patients.", "population_specificity": "Female patients with hepatocellular adenoma (HCA) and a median preintervention BMI of 41 kg/m\u00b2.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:56.863352+00:00"}
{"study_id": 113932, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to provide an overview of interventions to help women achieve a healthy weight between pregnancies by improving gestational weight gain.", "results_summary": "The abstract discusses the risks of excessive gestational weight gain and the benefits of limiting it to recommended levels, but does not mention bariatric surgery or its effects.", "population_specificity": "Women with excessive gestational weight gain and postpartum weight retention.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:57.070196+00:00"}
{"study_id": 113923, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to determine whether bariatric surgery could help patients with end-stage heart failure (ESHF) and ventricular assist devices (VADs) reduce their BMI below 35 kg/m\u00b2 to become eligible for heart transplantation.", "results_summary": "The study included 29 patients and tracked their BMI outcomes post-bariatric surgery, with the composite outcome being achieving a BMI < 35 kg/m\u00b2. Long-term outcomes were assessed, but specific efficacy details are not provided in the abstract.", "population_specificity": "Patients with end-stage heart failure (ESHF) treated with ventricular assist devices (VADs) and a BMI \u2265 35 kg/m\u00b2.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:57.101326+00:00"}
{"study_id": 113933, "supplement_id": 913, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the surgical morbidity of laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gastric bypass (LRYGB) in obese patients aged 65 years or older.", "results_summary": "The study found that morbidity and mortality rates of bariatric surgery were low in elderly obese patients. LSG had a lower rate of severe complications compared to LRYGB, though the difference was not statistically significant.", "population_specificity": "Obese patients aged \u226565 years with a BMI between 35.5 and 52.8 kg/m\u00b2.", "effective_dosage": "Not Assessed", "study_duration": "September 2017 to May 2019 (approximately 20 months)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:57.206878+00:00"}
{"study_id": 113931, "supplement_id": 913, "safety_score": "80", "efficacy_score": 90, "quality_score": 70, "study_goal": "The researchers aimed to review emerging technologies for obesity treatment, comparing their safety, efficacy, and weight loss outcomes to bariatric surgery and conservative treatments.", "results_summary": "Emerging therapies showed improved glucose metabolism in diabetic patients and better weight loss than conservative treatments, though not surpassing bariatric surgery, with a low adverse event rate. The study emphasizes multidisciplinary management for new techniques.", "population_specificity": "General obesity population, including diabetic patients.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:57.489839+00:00"}
{"study_id": 113934, "supplement_id": 913, "safety_score": "75", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to describe the incidence and factors associated with severe nutritional complications following adult bariatric surgery.", "results_summary": "The study found that severe nutritional complications after bariatric surgery are rare but comparable to other major complications, with malnutrition or nutrient deficiency leading to hospital admission being the primary outcome. The majority of patients underwent Roux-en-Y gastric bypass, and the mean preoperative BMI was high (49.3 \u00b1 8.0 kg/m\u00b2).", "population_specificity": "Ontario adults (81.8% female, mean age 45.1 \u00b1 10.6 years) who underwent bariatric surgery between 2009 and 2015.", "effective_dosage": "Not Assessed", "study_duration": "Study period covered surgeries from January 1, 2009, to December 31, 2015.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:59.214371+00:00"}
{"study_id": 113936, "supplement_id": 913, "safety_score": "70", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to update nutritional guidelines for bariatric surgery, focusing on preoperative and postoperative care to address micronutrient deficiencies.", "results_summary": "The study found that bariatric surgery is clinically and cost-effective for severe obesity but can lead to micronutrient deficiencies, necessitating long-term nutritional monitoring and supplementation. Updated guidelines include systematic evidence reviews and recommendations for safe clinical practice.", "population_specificity": "Adults and adolescents undergoing adjustable gastric band, sleeve gastrectomy, Roux-en-Y gastric bypass, and biliopancreatic diversion/duodenal switch.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:01.663268+00:00"}
{"study_id": 113937, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the effectiveness of bariatric surgery for hypothalamic obesity (HO) in patients with craniopharyngioma (CP).", "results_summary": "The study found that no generally accepted pharmacologic or bariatric therapy for HO in CP has been effective in randomized controlled trials, and prevention of HO is recommended.", "population_specificity": "Patients with hypothalamic obesity (HO) caused by craniopharyngioma (CP).", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:05.299005+00:00"}
{"study_id": 113938, "supplement_id": 913, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to assess the safety and outcomes of bariatric surgery during the SARS-CoV-2 outbreak and its potential role in minimizing COVID-19 effects in obese patients.", "results_summary": "The study found a low COVID-19 infection rate (0.6%) post-surgery with no mortality and comparable complication rates to pre-pandemic data, suggesting bariatric surgery remained safe and effective during the outbreak.", "population_specificity": "Obese patients (BMI > 30) undergoing bariatric surgery in eight high-volume Italian centers.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:05.348515+00:00"}
{"study_id": 113939, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the meal-related response of circulating succinate in patients with obesity and type 2 diabetes after bariatric surgery and examine the role of gastrointestinal glucose sensing in succinate dynamics in healthy subjects.", "results_summary": "The study found that the meal-related response of circulating succinate in patients with obesity and type 2 diabetes improved after metabolic surgery, suggesting a recovery in succinate dynamics post-intervention.", "population_specificity": "45 patients with morbid obesity and type 2 diabetes (BMI 39.4 \u00b1 1.9 kg/m\u00b2).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:05.970938+00:00"}
{"study_id": 113941, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to determine whether bariatric surgery is a suitable treatment for patients with obesity due to confirmed genetic defects (genetic obesity disorders).", "results_summary": "The study found that in monogenic non-syndromic obesity, genetic defects significantly influence bariatric surgery efficacy, while data for syndromic obesity is scarce and outcomes may be poorer in severe cases. Limited evidence supports bariatric surgery for genetic obesity, but it could be considered a last-resort option for selected patients with life-threatening comorbidities.", "population_specificity": "Patients with genetic obesity disorders (monogenic non-syndromic and syndromic obesity).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:06.900625+00:00"}
{"study_id": 113940, "supplement_id": 913, "safety_score": "70", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the nutritional management and outcomes of bariatric surgery, including pre-operative and post-operative phases, and its impact on weight loss and comorbidity reduction.", "results_summary": "Bariatric surgery is effective for long-term weight loss and reducing comorbidity burden, but it may lead to nutritional deficiencies and complications. Pre-operative weight loss does not improve post-surgery outcomes, but a modest 5-10% weight loss before surgery may reduce complications. Nutritional counseling and management are crucial post-surgery to address deficiencies and specific issues like dumping syndrome.", "population_specificity": "Patients with severe obesity.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:06.970792+00:00"}
{"study_id": 113942, "supplement_id": 913, "safety_score": "75", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to identify factors, beyond weight loss, that influence improvements in health-related quality of life (HRQoL) from before to 5 years after gastric bypass surgery.", "results_summary": "The study confirmed that weight loss significantly improves HRQoL after bariatric surgery, but preoperative depression medication and postoperative complications were associated with less improvement in HRQoL. Younger patients showed greater improvements in physical health scales, while differences by sex were minor.", "population_specificity": "Patients who underwent primary gastric bypass surgery in Sweden between 2008 and 2012, with HRQoL data available at baseline and 5-year follow-up (n=6998, 21% men).", "effective_dosage": "Not Assessed", "study_duration": "5-year follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:09.380730+00:00"}
{"study_id": 113943, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to assess the association of bariatric surgery with long-term mortality and the incidence of new-onset obesity-related diseases at a national level.", "results_summary": "Bariatric surgery was associated with reduced all-cause and cardiovascular mortality, as well as a lower incidence of type 2 diabetes, hypertension, dyslipidaemia, and ischemic heart disease. The study pooled data from large-scale population studies but noted limitations like unmeasured variables and heterogeneity in control groups.", "population_specificity": "Patients with obesity who underwent bariatric surgery (n=269,818) compared to control patients (n=1,270,086).", "effective_dosage": "Not specified", "study_duration": "Minimum follow-up of 18 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:11.475861+00:00"}
{"study_id": 113945, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the effectiveness of bariatric surgery compared to other therapeutic strategies for pediatric obesity.", "results_summary": "The study found that bariatric surgery, along with other therapeutic strategies like lifestyle correction and drugs, displayed low effectiveness in treating pediatric obesity. Prevention was suggested as a more promising approach than treatment.", "population_specificity": "Pediatric obesity patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:12.326677+00:00"}
{"study_id": 113944, "supplement_id": 913, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to compare the 30-day complication rates of minimally invasive bariatric surgery between adolescents and adults to assess perioperative safety.", "results_summary": "The study found that the 30-day complication rate was comparable between adolescents and adults (6.3% vs. 7.3%), with similar rates of intervention, reoperation, readmission, and mortality. The safety profile of bariatric surgery in adolescents was similar to that in adults, supporting its use in adolescents with morbid obesity.", "population_specificity": "Adolescents (age 19 or younger) and adults undergoing minimally invasive bariatric surgery.", "effective_dosage": "Not Assessed", "study_duration": "30-day follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:14.788937+00:00"}
{"study_id": 113946, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether changes in UCP1-3 expressions and their polymorphisms influence weight loss variability after bariatric surgery.", "results_summary": "The study found that UCP2 and UCP3 expressions in adipose tissue and skeletal muscle are affected by bariatric surgery, potentially influencing weight loss, while data on UCP1 remains inconclusive. Polymorphisms in UCP1-3 genes showed contradictory associations with weight loss outcomes.", "population_specificity": "Patients with severe obesity undergoing bariatric surgery.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:14.958312+00:00"}
{"study_id": 113948, "supplement_id": 913, "safety_score": "70", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the short-term renal effects of bariatric surgery (BS) and compare these effects between two forms of BS: laparoscopic sleeve gastrectomy (LSG) and laparoscopic one anastomosis gastric bypass (OAGB).", "results_summary": "Both LSG and OAGB resulted in significant reductions in body mass index (-27.1% \u00b1 7.11) and alleviated obesity-related renal changes, though postoperative hyperoxaluria remained a concern, particularly with OAGB. Radiological fat tissue analysis by CT may help predict renal outcomes post-BS.", "population_specificity": "57 patients with severe obesity.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:16.650274+00:00"}
{"study_id": 113947, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine if prophylactic use of ursodeoxycholic acid (UDCA) reduces the incidence of symptomatic gallstone disease after bariatric surgery.", "results_summary": "The study is designed to evaluate UDCA's effectiveness in preventing symptomatic gallstone disease post-bariatric surgery, with primary and secondary outcomes including gallstone development, cholecystectomies, side effects, and quality of life. Results were not yet available at the time of the abstract.", "population_specificity": "Patients with morbid obesity undergoing Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG).", "effective_dosage": "UDCA 900 mg daily", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:16.951225+00:00"}
{"study_id": 113949, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to identify biomarkers of subclinical atherosclerosis in morbidly obese patients and monitor changes in endothelial dysfunction after bariatric surgery.", "results_summary": "Patients with atheromatous plaque had worse cardiovascular risk profiles. Bariatric surgery reduced cardiovascular risk markers like vasa vasorum, oxidized LDL, and plasminogen activator inhibitor-1, with better prognosis for plaque-free patients.", "population_specificity": "66 patients with morbid obesity.", "effective_dosage": "Not specified", "study_duration": "12 months (follow-up at 6 and 12 months post-surgery)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:19.212723+00:00"}
{"study_id": 113950, "supplement_id": 913, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to summarize recent updates on the efficacy, safety, and durability of vertical sleeve gastrectomy (VSG) in adolescents as a treatment for moderate to severe obesity.", "results_summary": "VSG is effective for weight loss in adolescents, with similar five-year outcomes to adults, and has a complication rate ranging from 0 to 17.5%. The procedure is well-tolerated but remains underutilized despite its benefits.", "population_specificity": "Adolescents with moderate to severe obesity, particularly those with comorbidities.", "effective_dosage": "Not Assessed", "study_duration": "Five-year follow-up mentioned for weight loss outcomes.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:20.012302+00:00"}
{"study_id": 113935, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the impact of metabolic/bariatric surgery on type 2 diabetes mellitus, cardiovascular risk factors, and cardiovascular mortality.", "results_summary": "The study found that metabolic/bariatric surgery significantly improves cardiovascular risk factors and may reduce macrovascular events and cardiovascular mortality, though these latter findings require confirmation in randomized clinical trials.", "population_specificity": "Subjects who underwent metabolic/bariatric surgery between January 1, 2005, and June 1, 2020.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:20.529938+00:00"}
{"study_id": 113951, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to identify preoperative modifiable behavioral factors associated with postoperative weight loss outcomes in bariatric surgery patients.", "results_summary": "The study found mixed associations between preoperative modifiable behaviors (maladaptive eating behaviors, preoperative weight loss, tobacco use) and postoperative weight loss, with most studies reporting no association. Significant heterogeneity in outcome reporting limited quantitative synthesis.", "population_specificity": "Patients undergoing bariatric surgery with at least 2 years of follow-up.", "effective_dosage": "Not specified", "study_duration": "Minimum 2 years follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:21.120673+00:00"}
{"study_id": 113953, "supplement_id": 913, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the effectiveness and safety of sleeve gastrectomy (SG) and gastric bypass (GB) in treating obesity and its associated comorbidities.", "results_summary": "Both SG and GB were effective in weight loss and comorbidity remission, with GB showing higher remission rates for hypertension and dyslipidemia. SG had lower complication rates and shorter surgery duration.", "population_specificity": "3287 patients (78.6% female) presenting to a specialized bariatric center for primary bariatric procedures.", "effective_dosage": "Not Assessed", "study_duration": "24-month follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:23.544086+00:00"}
{"study_id": 113952, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to compare weight loss outcomes up to 60 months post-bariatric surgery between patients with high and low preoperative Binge Eating Scale (BES) scores.", "results_summary": "Patients with higher BES scores initially lost more weight (%TWL) at 24 months, but this difference disappeared by 60 months. Preoperative BES scores, depression, and age were not associated with long-term weight loss outcomes.", "population_specificity": "108 Brazilian patients who underwent Roux-en-Y gastric bypass.", "effective_dosage": "Not specified", "study_duration": "60 months (follow-up)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:23.639462+00:00"}
{"study_id": 113954, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers aimed to assess the effectiveness of interventions, including bariatric surgery, for managing obesity in individuals with bipolar disorder.", "results_summary": "No studies met the inclusion criteria, so the effectiveness of bariatric surgery for obesity management in bipolar disorder could not be determined. The review highlights the need for future research in this area.", "population_specificity": "Individuals with bipolar disorder and comorbid obesity (BMI \u2265 30 kg/m\u00b2).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:24.290197+00:00"}
{"study_id": 113955, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether bariatric surgery reduces diabetic renal, neurological, and ophthalmic complications in patients with obesity/overweight and type 2 diabetes compared to standard medical treatment.", "results_summary": "Bariatric surgery led to greater reductions in BMI, HbA1c, and urine albumin-creatinine ratio, improved glomerular filtration rate, and enhanced tuning fork vibration sensation, but showed no improvement in 10-g monofilament test, visual acuity, or diabetic retinopathy.", "population_specificity": "49 patients with obesity/overweight and type 2 diabetes receiving bariatric surgery, compared to 338 patients receiving standard medical treatment.", "effective_dosage": "Not specified", "study_duration": "2 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:27.353739+00:00"}
{"study_id": 113956, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "To evaluate the benefits of bariatric surgery on blood pressure control, particularly in patients with obesity and resistant hypertension.", "results_summary": "Bariatric surgery led to significant reductions in anti-hypertensive medication use while maintaining blood pressure control, with a notable proportion of hypertension remission compared to usual care. The GATEWAY trial sub-analysis showed a significant decrease in resistant hypertension prevalence after 12 months in the surgical group, unlike the control group.", "population_specificity": "Patients with obesity and hypertension, particularly those with resistant hypertension.", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:28.439651+00:00"}
{"study_id": 113958, "supplement_id": 913, "safety_score": "30", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to highlight the risk of lithium toxicity following bariatric surgery in patients with bipolar disorder and suggest monitoring and dosage adjustments post-surgery.", "results_summary": "The study found that bariatric surgery led to lithium toxicity in a patient, causing severe neurological sequelae. It emphasized the need for close lithium level monitoring and potential dosage adjustments post-surgery.", "population_specificity": "A 39-year-old man with morbid obesity and bipolar affective disorder.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Lithium toxicity post-sleeve gastrectomy", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:28.625278+00:00"}
{"study_id": 113957, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the incidence of gallstone formation between patients treated with ursodeoxycholic acid (UDCA) versus placebo for 6 months following bariatric surgery.", "results_summary": "UDCA significantly reduced gallstone formation at 6 months post-surgery compared to placebo. The study had a high dropout rate due to difficulties with medication adherence.", "population_specificity": "77.2% women, mean age 42.2 years, pre-surgery BMI 44.4 kg/m\u00b2.", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:29.376944+00:00"}
{"study_id": 113959, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to understand how surgeons, including those in bariatric surgery, perceive the value of patient-reported outcome measures (PROMs) in clinical practice.", "results_summary": "Surgeons in bariatric surgery and other subspecialties found PROMs valuable for enhancing clinical management, patient counseling, and detecting sensitive patient information, but identified obstacles such as implementation challenges and concerns about inappropriate use as performance metrics.", "population_specificity": "Surgeons from 5 subspecialties (including bariatric surgery) across 3 academic medical centers.", "effective_dosage": "Not available", "study_duration": "Not applicable (qualitative study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:29.920886+00:00"}
{"study_id": 113961, "supplement_id": 913, "safety_score": "65", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to investigate the association between bariatric surgery and the long-term incidence of gallstone disease.", "results_summary": "Bariatric surgery was associated with an increased risk of symptomatic gallstone disease and cholecystectomy, particularly in the first years following treatment, compared to the control group receiving usual obesity care.", "population_specificity": "3,597 individuals without previous or concomitant cholecystectomy from 25 surgery departments and 480 primary healthcare centers in Sweden.", "effective_dosage": "Not Assessed", "study_duration": "20 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:31.593006+00:00"}
{"study_id": 113960, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of liraglutide compared to placebo on weight loss when added early after laparoscopic sleeve gastrectomy (LSG) in obese individuals.", "results_summary": "Liraglutide significantly augmented weight loss from LSG, with greater %TWL and %EWL compared to placebo, and resolved dysglycemia in all diabetic/pre-diabetic patients in the liraglutide group. However, there was no significant difference in resolution of other obesity-related comorbidities between groups.", "population_specificity": "Obese individuals with BMI > 30 kg/m\u00b2 who underwent LSG.", "effective_dosage": "1.41 \u00b1 0.49 mg/day of liraglutide.", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:33.404398+00:00"}
{"study_id": 113962, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to review the role of gut hormones in energy homeostasis, their adaptations in obesity and after weight loss, and the potential of gut hormone-based therapies for obesity treatment, including insights from bariatric surgery.", "results_summary": "The study found that bariatric surgery leads to profound weight loss and metabolic improvements, likely due to adaptive alterations in gut hormone levels. It also highlighted the potential of gut hormone-based therapies, particularly dual or triple receptor agonists, to mimic these effects and improve obesity and glycaemia management.", "population_specificity": "Obese individuals and those with hyperglycaemia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:33.603224+00:00"}
{"study_id": 113964, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the impact of bariatric surgery on male obesity-associated gonadal dysfunction, focusing on its effects on serum testosterone concentrations and spermatogenesis.", "results_summary": "The study found that weight loss after bariatric surgery correlates with increased serum testosterone concentrations, surpassing results from lifestyle modifications alone. However, data on sperm and semen parameters remain controversial, and emerging evidence suggests paternal obesity can affect offspring metabolic and reproductive phenotypes via epigenetic reprogramming.", "population_specificity": "Men of reproductive age with obesity and associated infertility.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:36.752520+00:00"}
{"study_id": 113965, "supplement_id": 913, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the association between prior bariatric surgery and perioperative cardiovascular outcomes following noncardiac surgery in patients with type 2 diabetes mellitus.", "results_summary": "The study found that prior bariatric surgery was associated with a reduced risk of major adverse cardiovascular and cerebrovascular events (MACCEs), death, acute kidney injury, and acute respiratory failure in T2DM patients undergoing noncardiac surgery. The incidence of MACCEs was significantly lower in patients with prior bariatric surgery (1.01%) compared to those with morbid obesity (3.25%).", "population_specificity": "Patients with type 2 diabetes mellitus undergoing major noncardiac surgery.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:38.015717+00:00"}
{"study_id": 113966, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of bariatric surgery versus lifestyle intervention for treating obesity, type 2 diabetes mellitus, and nonalcoholic steatohepatitis.", "results_summary": "The study found that bariatric surgery is the only proven effective treatment for these metabolic disorders, whereas lifestyle intervention alone results in modest weight loss at mid and long term. However, bariatric surgery is offered to only a small percentage of patients due to its invasiveness and cost.", "population_specificity": "Patients with obesity, type 2 diabetes mellitus, and nonalcoholic steatohepatitis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:38.278173+00:00"}
{"study_id": 113963, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "To develop evidence-based recommendations and expert consensus for nutrition management of patients undergoing bariatric surgery and postoperative follow-up.", "results_summary": "The study recommends preoperative micronutrient screening, a VLCD for 4-8 weeks prior to surgery, a liquid diet postoperatively for a month followed by a semi-solid diet, adjusted protein intake, systematic multivitamin supplementation, higher doses of calcium citrate and vitamin D, and individualized use of proton-pump inhibitors. Specialized follow-up is emphasized for high-risk groups.", "population_specificity": "Patients undergoing bariatric surgery, with specific focus on pregnant women, teenagers, and elderly patients.", "effective_dosage": "Protein (1-1.5 g/kg adjusted weight), higher doses of calcium citrate and vitamin D (specific amounts not stated).", "study_duration": "Preoperative VLCD for 4-8 weeks, postoperative liquid diet for 1 month, semi-solid diet for 1 month.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:38.678744+00:00"}
{"study_id": 113968, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the potential of bariatric surgery as a therapeutic approach for obesity-induced heart failure with preserved ejection fraction (HFpEF).", "results_summary": "The study suggests that substantial weight reduction through bariatric surgery is a promising therapeutic approach for obesity-induced HFpEF, alongside lesser weight reduction via caloric restriction. Obesity-associated inflammation may contribute to HFpEF, and weight reduction interventions could mitigate these effects.", "population_specificity": "Middle-aged and elderly individuals with obesity and HFpEF, particularly noting differences in demographics (e.g., African American women) and comorbidities compared to elderly patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:40.436974+00:00"}
{"study_id": 113967, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the impact of bariatric surgery on the pharmacology of oral anticoagulants, particularly direct oral anticoagulants (DOACs).", "results_summary": "The study found that bariatric surgery reduces vitamin K antagonist (VKA) requirements for the same INR target but raises concerns about insufficient efficacy of dabigatran after gastric bypass. Rivaroxaban at prophylactic doses showed no impact post-surgery, but data for other anticoagulants or therapeutic DOAC doses remain inconclusive.", "population_specificity": "Patients who have undergone bariatric surgery, particularly those requiring oral anticoagulants.", "effective_dosage": "Dabigatran 150 mg twice daily; rivaroxaban 10 mg per day.", "study_duration": "Follow-up ranged from 3 days to 8 months post-surgery.", "interactions": "Potential impaired absorption of dabigatran after gastric bypass; no significant impact noted for rivaroxaban at prophylactic doses.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:40.909355+00:00"}
{"study_id": 113970, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to consolidate current understanding of the metabolic, macrovascular, and microvascular benefits of bariatric surgery and provide an update on its effects.", "results_summary": "Bariatric surgery improves obesity-related metabolic comorbidities, including dyslipidaemia, hypertension, T2DM, and inflammation, while also slowing atherosclerosis and reducing cardiovascular and all-cause mortality. Early metabolic benefits vary by surgery type, while long-term effects correlate with sustained weight loss.", "population_specificity": "Individuals with morbid obesity and related metabolic conditions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:41.727161+00:00"}
{"study_id": 113971, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize recent advances in hormonal and nutritional strategies for appetite control, including the role of appetite-control hormones in the efficacy of bariatric procedures.", "results_summary": "The study highlights that appetite-control hormones play a role in the efficacy of bariatric procedures, suggesting these procedures may help regulate energy intake. However, long-term safety and physiological mechanisms of some nutritional strategies remain unclear.", "population_specificity": "Not specified (general discussion of appetite control mechanisms and bariatric surgery)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:44.493571+00:00"}
{"study_id": 113974, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the necessity of resuming bariatric/metabolic surgery post-pandemic and proposed a priority ranking plan for patient selection.", "results_summary": "The study found that bariatric surgery provides prompt, lasting benefits for obesity and diabetes, which are major risk factors for severe Covid-19. It recommended resuming surgery with priority-based patient selection and strict infection control measures.", "population_specificity": "Individuals with obesity, particularly those with diabetes, who are candidates for bariatric/metabolic surgery.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:45.976609+00:00"}
{"study_id": 113969, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of regional adiposity in HFpEF and evaluate strategies like bariatric surgery for reducing adiposity and improving HFpEF-related outcomes.", "results_summary": "The study suggests that regional fat distribution, particularly epicardial and visceral fat, strongly associates with HFpEF risk. Bariatric surgery, along with exercise and diet, shows promise in reducing adiposity, but few studies focus on HFpEF-related outcomes in obese populations.", "population_specificity": "Obese individuals, particularly those with or at risk for HFpEF.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:46.487640+00:00"}
{"study_id": 113973, "supplement_id": 913, "safety_score": "70", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to review recent findings on postoperative outcomes of bariatric and metabolic surgery, focusing on weight loss, remission of obesity-related diseases, reflux, revisional surgery, robotic-assisted platforms, and adolescent populations.", "results_summary": "Sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) showed similar weight loss at 5 years, while duodenal switch (BPD/DS) achieved maximal weight loss and optimal comorbidity resolution. Surgery provided significant protection against coronary artery disease and heart failure, but SG was associated with high rates of postoperative GERD.", "population_specificity": "Adults and adolescents with obesity or obesity-related comorbidities.", "effective_dosage": "Not Assessed", "study_duration": "Up to 5 years (follow-up)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:46.895356+00:00"}
{"study_id": 113975, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy of a laparoscopically guided surgical TAP and RS block in reducing analgesic consumption and improving functional outcomes in patients undergoing laparoscopic bariatric surgery.", "results_summary": "The study is ongoing, and results are not yet reported; it focuses on comparing postoperative narcotic use, pain scores, functional outcomes, and quality of recovery between intervention and placebo groups.", "population_specificity": "150 patients living with obesity undergoing elective laparoscopic Roux-En-Y gastric bypass.", "effective_dosage": "60 mL 0.25% ropivacaine, divided into four injections (two for TAP and two for RS block).", "study_duration": "6 months (recruitment period; intervention duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:47.738302+00:00"}
{"study_id": 113977, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the percentage of T2DM patients meeting DSS-II eligibility criteria for bariatric surgery, their awareness of BS as an option, and associated characteristics.", "results_summary": "The study found that eligibility rates for BS in T2DM patients remain low, with limited data on how many eligible patients are informed about BS. It also examined demographic and clinical factors linked to eligibility and awareness.", "population_specificity": "T2DM patients visiting outpatient clinics at three large-volume university hospitals.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:48.683129+00:00"}
{"study_id": 113976, "supplement_id": 913, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the incidence of gallstone formation after prophylactic administration of ursodeoxycholic acid (UDCA) in patients undergoing one anastomosis gastric bypass (OAGB).", "results_summary": "The study found that UDCA administration significantly reduced gallstone incidence (4.2% in the UDCA group vs. 25.2% in the control group) after OAGB, with no reported intolerance. No significant difference in quality of life scores was observed between the groups.", "population_specificity": "Patients undergoing one anastomosis gastric bypass (OAGB).", "effective_dosage": "600 mg/day of oral UDCA.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:49.414665+00:00"}
{"study_id": 113978, "supplement_id": 913, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety and efficacy of bariatric surgery in inflammatory bowel disease (IBD) patients and its impact on IBD course.", "results_summary": "The study found that bariatric surgery has an acceptable safety profile in IBD patients, with pooled adverse event rates of 15.9% (early) and 16.9% (late). Efficacy was demonstrated by a 66.1% excess weight loss and 13.7 kg/m\u00b2 BMI reduction at 12 months, with nearly half of patients reducing IBD medications.", "population_specificity": "Inflammatory bowel disease (IBD) patients undergoing bariatric surgery.", "effective_dosage": "Not Assessed", "study_duration": "12-month follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:50.898386+00:00"}
{"study_id": 113979, "supplement_id": 913, "safety_score": "80", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine whether the transversus abdominis plane (TAP) block provides effective postoperative analgesia in patients undergoing bariatric surgery.", "results_summary": "The study found that TAP block significantly reduced pain scores at rest up to 24 postoperative hours compared to the control group, though dynamic pain scores and morphine consumption at 2 hours were not significantly different. Block-related complications were not significantly different between groups, and the overall evidence quality was moderate-to-low.", "population_specificity": "Patients undergoing bariatric surgery (1,025 participants across 13 trials).", "effective_dosage": "Not specified", "study_duration": "Postoperative outcomes assessed up to 24 hours.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:53.143815+00:00"}
{"study_id": 113981, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore patients' and healthcare professionals' experiences with integrating patient-reported outcome monitoring (PRO/CFS) into bariatric surgery care.", "results_summary": "The study describes a planned implementation of PRO/CFS in bariatric outpatient clinics, focusing on HRQOL, mental health, and other outcomes, but does not yet report specific findings on efficacy or outcomes.", "population_specificity": "Patients undergoing bariatric surgery at two outpatient clinics.", "effective_dosage": "Not applicable", "study_duration": "Assessments at pre-surgery, 3 months, and 12 months post-surgery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:54.409917+00:00"}
{"study_id": 113982, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate the role of genetic testing and personalized nutrition in managing micronutrient deficiencies associated with bariatric surgery.", "results_summary": "Studies found associations between genetic variants and micronutrient metabolism, suggesting genetic testing could predict outcomes in bariatric surgery patients. However, research on genetic variants specific to bariatric surgery and micronutrient deficiencies remains limited.", "population_specificity": "Morbidly obese individuals undergoing or having undergone bariatric surgery.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:55.468462+00:00"}
{"study_id": 113980, "supplement_id": 913, "safety_score": "75", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the feasibility, safety, and efficacy of robotic-assisted management (magnetic sphincter augmentation or conversion to Roux-en-Y gastric bypass) for treating intractable GERD following sleeve gastrectomy.", "results_summary": "The study found that robotic-assisted approaches for GERD post-sleeve gastrectomy had low morbidity and high success rates (>80% PPI discontinuation), with no significant differences in intraoperative/postoperative morbidity between groups, though operative times varied.", "population_specificity": "Patients with GERD after sleeve gastrectomy (MSA-S and RYGB groups) or GERD without prior bariatric surgery (MSA group) at a tertiary-care bariatric center (2015\u20132019).", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:55.721046+00:00"}
{"study_id": 113984, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the clinical features, diagnosis, and treatment of Wernicke's encephalopathy, particularly highlighting non-traditional causes such as post-bariatric surgery.", "results_summary": "The abstract notes that Wernicke's encephalopathy, caused by thiamine deficiency, is increasingly recognized in non-alcoholic populations, including post-bariatric surgery patients, and emphasizes the importance of early diagnosis and treatment to prevent permanent disability.", "population_specificity": "Patients following bariatric surgery, gastrointestinal surgery, cancer, and pancreatitis.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:56.738268+00:00"}
{"study_id": 113983, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the impact of bariatric surgery on health-related quality of life (HRQL) and compare the evidence available on physical and mental health outcomes post-surgery.", "results_summary": "The study found that physical aspects of HRQL improve more than mental health aspects after bariatric surgery, with peak benefits observed 1-2 years post-surgery. However, comparative HRQL analyses between procedures were limited due to a lack of randomized data, and qualitative research highlighted patient tensions post-surgery.", "population_specificity": "Patients undergoing bariatric surgery (specific demographics not detailed).", "effective_dosage": "Not mentioned", "study_duration": "Follow-up period of 1-2 years post-surgery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:57.091523+00:00"}
{"study_id": 113985, "supplement_id": 913, "safety_score": "70", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of metabolic surgery in treating type 2 diabetes and its complications, while identifying gaps in current knowledge.", "results_summary": "The study found that metabolic surgery is superior to medical therapy alone for achieving glycaemic and metabolic targets in type 2 diabetes, with potential benefits for diabetic kidney disease. However, effects on complications like retinopathy or neuropathy remain uncertain, with possible post-operative deterioration.", "population_specificity": "Patients with obesity-associated type 2 diabetes, including those with and without complications.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:57.788538+00:00"}
{"study_id": 113986, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to examine changes in energy and macronutrient intake after bariatric surgery and establish nutritional guidelines for achieving target weight loss.", "results_summary": "The study found that successful weight loss after bariatric surgery was associated with lower carbohydrate and fat intake, with specific cutoff values for calorie and protein intake at different postoperative intervals. Compliance with these nutrient recommendations was linked to long-term weight loss success.", "population_specificity": "189 morbidly obese patients who underwent bariatric surgery.", "effective_dosage": "Not applicable (surgical intervention).", "study_duration": "12 months post-operation.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:59.030257+00:00"}
{"study_id": 113987, "supplement_id": 913, "safety_score": "65", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to describe possible complications, ailments, and important follow-up considerations after bariatric surgery to improve long-term outcomes.", "results_summary": "Bariatric surgery is effective and durable for obesity treatment but is associated with surgical and medical complications, including dumping syndrome and malnutrition. Adequate lifelong monitoring is crucial for reducing complications and achieving lasting results.", "population_specificity": "Severely obese patients who failed non-surgical weight loss interventions.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:00.288446+00:00"}
{"study_id": 113988, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review predictive factors for outcomes of bariatric surgery, including weight loss, weight regain, diabetes remission, and recurrence, to improve patient selection and post-operative care.", "results_summary": "The study found that bariatric surgery is effective for weight loss and comorbidity reduction but outcomes vary among patients. Post-operative behaviors and lifestyle changes are more influential than pre-operative predictors for long-term success.", "population_specificity": "Patients with severe obesity undergoing bariatric surgery.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:03.105172+00:00"}
{"study_id": 113990, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to identify expected pharmacokinetic changes and provide practical recommendations for medication management of chronic diseases after bariatric surgery.", "results_summary": "The study found that pharmacokinetic changes after bariatric surgery vary by surgery type and provided guiding principles for medication management, along with practice tips for specific chronic disease states. It concluded that long-term medication regimens should be adjusted in an evidence-based manner post-surgery.", "population_specificity": "Human adults undergoing bariatric surgery.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:03.395558+00:00"}
{"study_id": 113991, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to review surgical techniques in gastric surgery and describe imaging appearances of postoperative changes and complications.", "results_summary": "The study highlights the challenges of interpreting imaging after gastric surgery due to anatomical modifications and emphasizes the importance of recognizing normal postoperative changes and complications. It reviews various surgical techniques but does not provide specific efficacy or safety outcomes for bariatric surgery.", "population_specificity": "Patients who underwent gastric surgery (not specifically bariatric surgery).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:04.305624+00:00"}
{"study_id": 113989, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether butorphanol, a KOR agonist, could protect pulmonary function in obese patients undergoing laparoscopic bariatric surgery.", "results_summary": "Butorphanol improved oxygenation and reduced dead space ventilation compared to the control group, with lower levels of pulmonary injury biomarkers postoperatively, though the incidence of PPCs was similar between groups.", "population_specificity": "Obese patients (BMI \u2265 30 kg/m\u00b2) undergoing laparoscopic bariatric surgery.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Measured at 1h after operation start, end of operation, 1h after extubation, and postoperatively at 3h, 6h, 12h, and 24h.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:04.411107+00:00"}
{"study_id": 113992, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the neurobiological aspects of obesity causation and treatment, focusing on the effectiveness of bariatric surgery and GLP-1R agonist therapies in influencing food reward and motivational drive to overeat.", "results_summary": "The study highlights that bariatric surgery and GLP-1R agonist therapies effectively target the pathophysiology of obesity by modulating brain appetitive control circuits, reducing hyperphagia, and improving weight loss outcomes compared to behavioral therapy alone.", "population_specificity": "Individuals with obesity.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:04.821492+00:00"}
{"study_id": 113993, "supplement_id": 913, "safety_score": "85", "efficacy_score": 90, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the safety, efficacy, and outcomes of bariatric surgery in patients with paraplegia and severe obesity, given the lack of existing evidence for this specific population.", "results_summary": "The study found that bariatric surgery led to significant weight loss, improved mobility, and enhanced quality of life in patients with paraplegia, with no significant post-operative complications reported in the reviewed cases.", "population_specificity": "Patients with severe obesity and paraplegia.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:05.451278+00:00"}
{"study_id": 113994, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare weight loss outcomes and long-term effects of non-banded versus banded Roux-en-Y gastric bypass (B-RYGB) in superobese patients (BMI \u226550 kg/m\u00b2).", "results_summary": "The study will evaluate weight loss, non-response rates, reduction of obesity-related comorbidities, complications, and patient satisfaction over a 10-year follow-up period, but results are not yet provided in the abstract.", "population_specificity": "Superobese patients (BMI \u226550 kg/m\u00b2).", "effective_dosage": "A 7.0-8.0 cm silastic ring (MiniMizer\u00ae) placed proximal to the gastrojejunostomy for B-RYGB.", "study_duration": "10-year follow-up.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:08.122679+00:00"}
{"study_id": 113996, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the latest developments in bariatric endoscopy, including primary and secondary procedures, to address the treatment gap for obesity classes not adequately served by surgery.", "results_summary": "The study highlights that bariatric surgery provides sustainable results for morbid obesity, while endoscopic procedures offer less invasive alternatives for lower and middle obesity classes and help manage complications from bariatric surgeries. Innovative endoscopic techniques and implants are emerging as effective tools in obesity treatment.", "population_specificity": "Patients with morbid obesity and lower/middle obesity classes (defined by BMI).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:11.314309+00:00"}
{"study_id": 113999, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy of enteral nutrition (EN) versus total parenteral nutrition (TPN) in treating postoperative upper gastrointestinal fistula (PUGIF) following bariatric surgery and other major upper GI surgeries.", "results_summary": "The study hypothesizes that EN increases the 30-day fistula closure rate in PUGIF, improving health-related quality of life without increasing morbidity or mortality, but results are pending as it is a planned randomized trial.", "population_specificity": "Patients with PUGIF after esophagogastric resection (including bariatric surgery), duodenojejunal resection, or pancreatic resection with digestive tract violation.", "effective_dosage": "Not specified", "study_duration": "Outcomes assessed at 30 days and 6 months post-randomization.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:14.114119+00:00"}
{"study_id": 113998, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the short-term impact of sleeve gastrectomy (SG) on cardiac autonomic function (CAF) and its relationship with weight loss in women with obesity.", "results_summary": "SG was effective at reducing excess weight and improving heart rate variability (HRV) within the first month after surgery, with these improvements detectable as early as one month post-operation. HRV assessment showed promise as a low-cost tool for monitoring these changes.", "population_specificity": "23 female patients with obesity (mean age 36.0 \u00b1 11.1 years, BMI 35.1 \u00b1 3.4 kg/m\u00b2).", "effective_dosage": "Not applicable (surgical intervention).", "study_duration": "3 months (assessed pre-surgery and at 1 and 3 months post-surgery).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:14.739012+00:00"}
{"study_id": 114000, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine the role of endoscopy before and after bariatric surgery for managing adiposity and related chronic diseases.", "results_summary": "The study issued a position statement based on clinical knowledge, expert opinion, and peer-reviewed evidence, but specific outcomes or effects of bariatric surgery were not detailed.", "population_specificity": "Patients seeking surgery for adiposity-based chronic diseases.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:14.790734+00:00"}
{"study_id": 114001, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether weight loss alone or metabolic changes from bariatric surgery were responsible for reduced cancer risk in obese populations.", "results_summary": "The study found that bariatric surgery reduced cancer risk by approximately 50% in participants with 20% to 34.9% total weight loss compared to those with <20%. Improvements in glucose, proinsulin, insulin, leptin, and ghrelin levels were also associated with decreased cancer risk.", "population_specificity": "2,458 participants (79% female, mean age 46) from ten U.S. clinical facilities.", "effective_dosage": "Not specified", "study_duration": "Follow-up over 8,759 person-years (measurements taken preoperatively and 1 year postoperatively).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:14.882242+00:00"}
{"study_id": 114002, "supplement_id": 913, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether routine preoperative esophagogastroduodenoscopy (p-EGD) should be performed before bariatric surgery by analyzing its impact on surgical plans and patient outcomes.", "results_summary": "The study found that for 82% of patients, routine p-EGD did not alter the surgical plan or postpone surgery, while 16% required changes or delays, and 0.4% had absolute contraindications. The findings question the necessity of routine p-EGD due to its invasive nature and unclear effectiveness.", "population_specificity": "Obese patients undergoing bariatric surgery (10,685 patients across 25 studies).", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:16.782095+00:00"}
{"study_id": 113995, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether postoperative administration of GLP-1 analogues could enhance weight loss and comorbidity improvements in patients with unsatisfactory results after bariatric surgery.", "results_summary": "The study found that GLP-1 analogues may promote additional weight loss and type 2 diabetes remission postoperatively, suggesting potential benefits for patients with suboptimal outcomes after bariatric surgery. However, only one randomized controlled trial was identified among the reviewed studies.", "population_specificity": "Patients with severe obesity who underwent bariatric surgery and had unsatisfactory long-term results.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:18.249307+00:00"}
{"study_id": 114003, "supplement_id": 913, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to review the history, current state, and future of bariatric and metabolic surgery, including endoscopic treatments for obesity, and to discuss challenges and recommendations for expanding patient eligibility.", "results_summary": "The study found that both surgical and endoscopic treatments for obesity lead to significant weight loss and comorbidity reduction, though broader implementation and updated patient selection criteria are needed. Long-term improvements in morbidity and mortality have been achieved, but further enhancements are possible.", "population_specificity": "Individuals with obesity (specific demographics not detailed).", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:19.432731+00:00"}
{"study_id": 114005, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "To assess the availability and distribution of specialized public obesity care services, including bariatric surgery, across Italy.", "results_summary": "The study found an uneven distribution of obesity-focused facilities in Italy, with an inverse correlation between regional obesity prevalence and facility availability. Surgery-oriented centers were more widely distributed than medically oriented ones, but insufficient data was available for a detailed analysis of their characteristics.", "population_specificity": "Italian healthcare system and regional obesity care services.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:21.981158+00:00"}
{"study_id": 114006, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the critical components and considerations for optimal nutrition care in patients undergoing bariatric surgery, focusing on pre- and postoperative phases.", "results_summary": "The study highlights that bariatric surgery is the most effective treatment for severe obesity but notes varying risks of nutrient deficiencies based on surgery type and nutrition intervention. It emphasizes the role of a specialized dietitian in achieving and maintaining optimal nutrition status and calls for lifelong follow-up.", "population_specificity": "Patients with severe and complex obesity undergoing bariatric surgery.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:22.810589+00:00"}
{"study_id": 113997, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether sleeve gastrectomy (SG) is non-inferior to Roux-en-Y gastric bypass (RYGB) in terms of total body weight loss in adolescents with severe obesity.", "results_summary": "The abstract does not report results, as the study is ongoing. The primary outcome will measure the proportion of participants achieving 20% total body weight loss at 3 years postoperatively, with secondary outcomes including changes in BMI, adverse health events, comorbidity resolution, and quality of life.", "population_specificity": "Adolescents aged 13-17 (Tanner stage \u2265IV) with severe obesity.", "effective_dosage": "Not applicable (surgical intervention).", "study_duration": "Follow-up extends into the long term, with primary outcome measured at 3 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:22.873488+00:00"}
{"study_id": 114007, "supplement_id": 913, "safety_score": "70", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the short and long-term results of revisional bariatric surgery for insufficient weight loss or weight regain after laparoscopic Roux-en-Y gastric bypass (LRYGB).", "results_summary": "The study found that banded bypass provided modest additional weight loss and helped patients with dumping syndrome, while biliopancreatic diversion (BPD) achieved greater weight loss but had a higher reoperation risk. Revisional surgery was rare but effective in carefully selected cases.", "population_specificity": "Patients who underwent revisional bariatric surgery after LRYGB for insufficient weight loss (n=54).", "effective_dosage": "Not Assessed", "study_duration": "Follow-up of at least 1 year (revisional surgery performed 3.3 \u00b1 2.3 years after LRYGB in the banded group and 6.4 \u00b1 4.3 years in the BPD group).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:24.682284+00:00"}
{"study_id": 181168, "supplement_id": 920, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to determine if dietary supplementation with Benfotiamine could help control blood glucose in patients with type 2 diabetes mellitus (T2DM).", "results_summary": "The abstract does not provide specific results regarding Benfotiamine's effects on blood glucose control or other outcomes.", "population_specificity": "Patients with type 2 diabetes mellitus (T2DM).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:31.392498+00:00"}
{"study_id": 181171, "supplement_id": 920, "safety_score": "80", "efficacy_score": 20, "quality_score": 85, "study_goal": "To determine the effects of long-term benfotiamine supplementation on peripheral nerve function and inflammatory markers in type 1 diabetes patients.", "results_summary": "Benfotiamine significantly increased thiamine levels but showed no significant effects on peripheral nerve function or inflammatory biomarkers compared to placebo.", "population_specificity": "Patients with type 1 diabetes (n=67, 59 completed).", "effective_dosage": "300 mg/day", "study_duration": "24 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:31.488660+00:00"}
{"study_id": 3506, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Berberine improves non-motor symptoms (depression and gastrointestinal dysfunction) in a Parkinson's disease rat model.", "results_summary": "Berberine improved depression-like behaviors, increased dopamine and serotonin in the midbrain, enhanced gastrointestinal function, and modulated enteric neurotransmitters and glial cells in Parkinson's disease rats.", "population_specificity": "6-hydroxydopamine-induced (6-OHDA) Parkinson's disease rats", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:31.878073+00:00"}
{"study_id": 181172, "supplement_id": 920, "safety_score": "Not Assessed", "efficacy_score": 40, "quality_score": 70, "study_goal": "The researchers aimed to determine whether Benfotiamine could prevent or reverse early-stage diabetic nephropathy in experimental and clinical settings.", "results_summary": "Benfotiamine prevented early-stage diabetic nephropathy in experimental studies but failed to produce similar clinical effects in human trials. The abstract suggests possible explanations for this discrepancy but does not detail them.", "population_specificity": "Diabetic rats and patients with type 2 diabetes and microalbuminuria.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:32.012819+00:00"}
{"study_id": 3508, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of combining Berberine (BBR) with anti-PD-L1 on hepatocellular carcinoma (HCC) tumorigenesis, proliferation, migration, and invasion.", "results_summary": "BBR significantly inhibited HCC cell proliferation, and its combination with anti-PD-L1 markedly suppressed tumorigenesis, migration, and invasion by inactivating Erk phosphorylation. The treatment also affected immune subsets in tumors.", "population_specificity": "Hep-3B and HCCLM3 hepatocellular carcinoma cell lines.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:32.611080+00:00"}
{"study_id": 3505, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to explore berberine's therapeutic potential in mitigating metabolic dysfunction-associated steatotic liver disease (MASLD) and elucidate its mechanisms of action, focusing on glucose and lipid metabolism modulation via PI3K/Akt and STING pathways.", "results_summary": "Berberine significantly reduced hepatic steatosis, inflammation, and glucose intolerance, improved insulin sensitivity, and modulated lipid metabolism genes by activating PI3K/Akt and suppressing STING pathways in both in vivo and in vitro models.", "population_specificity": "Male C57BL/6J mice and HepG2 cells.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:32.861861+00:00"}
{"study_id": 3509, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to summarize the effects of Berberine (BBR) on depression by reviewing in vitro and in vivo experiments to assess its potential as a multi-target antidepressant.", "results_summary": "BBR demonstrated indirect antidepressant properties by modulating gut microbiota, strengthening the intestinal barrier, increasing short-chain fatty acid-producing bacteria, and regulating tryptophan metabolism. It also showed antidepressant-like effects via pathways such as Nrf2/ARE, HPA axis, and PPAR-delta, though further clinical trials are needed.", "population_specificity": "Not specified (in vitro and in vivo studies reviewed, no human population detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:32.869291+00:00"}
{"study_id": 3507, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate and compare the effectiveness of berberine (BER) and ellagic acid (EA), alone and in combination, in treating hind limb ischemia-reperfusion (I/R) injury in rats.", "results_summary": "Berberine reduced oxidative stress markers (MDA), increased antioxidant levels (GSH, SOD, CAT), normalized apoptosis (Bax, Bcl-2) and pyroptosis (Nrf2, NLRP3, Gasdermin D) pathways, and reduced histopathological damage in muscle tissue. The combination of BER and EA showed the most significant reduction in damage.", "population_specificity": "Male Sprague Dawley rats with induced hind limb I/R injury.", "effective_dosage": "200 mg/kg, intraperitoneal (single dose at the 75th minute of ischemia).", "study_duration": "Acute intervention (2-hour reperfusion period).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:34.778822+00:00"}
{"study_id": 3513, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop a brain-targeted delivery system using berberine-inspired ionizable lipids to improve BBB penetration and nucleic acid stability for neurological disease therapy.", "results_summary": "The study found that berberine-inspired nanoparticles enhanced brain uptake, improved nucleic acid stability, and showed therapeutic potential in murine models of Alzheimer's disease, glioma, and cryptococcal meningitis. The system also demonstrated minimal immunogenicity and inherent neuroprotective properties.", "population_specificity": "Murine models (mice)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:39.925342+00:00"}
{"study_id": 3512, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of berberine (BBR) combined with ferulic acid (FA) in a microneedle syringe for treating psoriasis by enhancing drug delivery and modulating inflammatory responses.", "results_summary": "The microneedle syringe improved transepidermal drug delivery, and BBR-FA nanoparticles inhibited microbial proliferation, scavenged reactive oxygen species, suppressed keratinocyte growth, and modulated macrophage polarization to reduce inflammation.", "population_specificity": "Patients with psoriasis (specific demographics not detailed).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:39.947310+00:00"}
{"study_id": 3511, "supplement_id": 921, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether a salt formulation of berberine (BBR) and quercetin (QR) (BQS) could enhance their combined anti-fibrotic effects in liver fibrosis compared to a physical mixture (BQP).", "results_summary": "BQS significantly improved the dissolution efficiency and bioavailability of QR, matching BBR levels, and demonstrated superior anti-fibrotic effects in both human hepatic stellate cells (LX-2) and a mouse model of hepatic fibrosis by modulating lipid accumulation, inflammation, apoptosis, and the cell cycle.", "population_specificity": "Human hepatic stellate cell line LX-2 and mice with methionine and choline-deficient (MCD) diet-induced hepatic fibrosis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:40.557387+00:00"}
{"study_id": 3516, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether exercise, berberine, or their combination could improve MAFLD by modulating gut microbiota and hepatic fatty acid beta-oxidation.", "results_summary": "Berberine effectively reduced liver lipid accumulation, restored gut microbiota diversity, and upregulated hepatic fatty acid beta-oxidation proteins (ACOX1, HMGCS2, CPT-1\u03b1), with the combined intervention showing the most significant effects.", "population_specificity": "Mice fed a high-fat diet to induce MAFLD.", "effective_dosage": "300 mg/kg, once daily for 8 weeks.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:41.051191+00:00"}
{"study_id": 3510, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the synergistic potential of berberine (BBR) and curcumin (CUR) co-crystals in a nanohydrogel formulation for enhanced therapeutic delivery and dual targeting mechanisms in endometrial cancer.", "results_summary": "The CUR/BBR nanohydrogel demonstrated superior efficacy with an IC50 of 12.36 \u03bcg/mL against HEC-59 endometrial cancer cells, outperforming individual components and Camptothecin. The dual binding mechanism of CUR and BBR enhanced apoptotic activity by disrupting caspase-3 functions.", "population_specificity": "HEC-59 endometrial cancer cells (in vitro study).", "effective_dosage": "Not specified (IC50 reported as 12.36 \u03bcg/mL for the nanohydrogel formulation).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:41.182246+00:00"}
{"study_id": 3514, "supplement_id": 921, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the renoprotective effects of berberine and elucidate its molecular mechanisms in treating various renal diseases.", "results_summary": "The study found that berberine exhibits a broad spectrum of pharmacological activities, including antioxidant properties, blood glucose reduction, lipid modulation, and anti-inflammatory effects, with significant potential for treating renal diseases like diabetic nephropathy, renal fibrosis, and kidney toxicity. It also highlighted berberine's wide therapeutic safety margin when administered orally.", "population_specificity": "Patients with renal diseases, including diabetic nephropathy, renal fibrosis, renal aging, and kidney toxicity induced by chemotherapy and antibiotics.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:41.474309+00:00"}
{"study_id": 3517, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the mechanisms of action of berberine and its clinical relevance in managing dermatologic diseases.", "results_summary": "The study highlights berberine's broad pharmacological properties, including antioxidant effects and gut microbiome regulation, suggesting its potential for treating complex skin disorders like acne, psoriasis, and skin aging.", "population_specificity": "Not specified (general dermatologic conditions).", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:42.029636+00:00"}
{"study_id": 3515, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether the combination of Berberine (BBR) and caffeine (CAF) offers neuroprotective effects against Parkinson's disease (PD)-related impairments compared to metformin (MTF) in a rotenone-induced rat model.", "results_summary": "The combination of BBR and CAF prevented motor deficits, weight reduction, dopamine depletion, and monoamine oxidase activity, while reducing inflammation and \u03b1-synuclein aggregation. It also normalized tyrosine hydroxylase levels and increased protein phosphatase 2A activity, showing superior neuroprotective effects compared to monotherapy or MTF.", "population_specificity": "Rotenone-induced rat model of Parkinson's disease.", "effective_dosage": "BBR (25 mg/kg/day) and CAF (2.5 mg/kg/day).", "study_duration": "Four weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:42.690446+00:00"}
{"study_id": 3520, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of berberine liposome-modified bone cement in treating Staphylococcus aureus-induced osteomyelitis in a rat model.", "results_summary": "The berberine liposome-modified bone cement showed favorable biodegradability, sustained drug release (over 90% within 14 days), effective biofilm eradication (up to 80%), and facilitated bone repair (80% bone volume fraction). The treatment demonstrated efficacy in addressing tibial osteomyelitis in rats.", "population_specificity": "Rat model of Staphylococcus aureus-induced osteomyelitis.", "effective_dosage": "Not specified in the abstract.", "study_duration": "14 days (based on drug release data).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:48.448218+00:00"}
{"study_id": 3521, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the protective effects of berberine on myocardial tissue in a rat model of ischemia-reperfusion injury and explore the role of the miR-184/NOTCH1 signaling pathway.", "results_summary": "Berberine significantly reduced myocardial infarct size, improved hemodynamic parameters, and attenuated apoptosis. The miR-184 inhibitor also demonstrated protective effects by modulating key signaling pathways involved in myocardial injury.", "population_specificity": "Male Wistar rats", "effective_dosage": "100 mg/kg/day orally", "study_duration": "2 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:48.513540+00:00"}
{"study_id": 3523, "supplement_id": 921, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to identify the neuroprotective effects of berberine chloride (BC) against aluminium chloride-induced Alzheimer's disease in zebrafish larvae by examining oxidative stress and neuroinflammation.", "results_summary": "BC mitigated biochemical and behavioral changes induced by AlCl3, reduced cholesterol and triglyceride levels, and interacted with the ABCA1 protein, suggesting potential as a therapeutic agent for Alzheimer's disease.", "population_specificity": "Zebrafish larvae", "effective_dosage": "Up to 40 \u03bcM (no developmental abnormalities), LC50 at 50.16 \u03bcM", "study_duration": "96 hours post fertilization", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:49.433245+00:00"}
{"study_id": 3519, "supplement_id": 921, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to assess the safety and efficacy of berberine ursodeoxycholate (HTD1801) in patients with type 2 diabetes inadequately controlled by diet and exercise.", "results_summary": "HTD1801 significantly reduced HbA1c levels in a dose-dependent manner, improved glycemic and cardiometabolic parameters, and was well tolerated with mostly mild adverse events. The 1000 mg dose also showed reductions in lipids and liver injury markers.", "population_specificity": "Patients with type 2 diabetes (mean age 54.3 years, 63.7% male) in China with HbA1c levels of 7.0% to 10.5% and fasting plasma glucose <250.5 mg/dL.", "effective_dosage": "500 mg twice daily and 1000 mg twice daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:49.760258+00:00"}
{"study_id": 3525, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to explore berberine's protective effects against rheumatoid arthritis (RA) and clarify the role of ATF3 in its mechanism of action.", "results_summary": "Berberine reduced proinflammatory cytokines and MMPs in LPS-stimulated synovial cells and CIA mice, mediated by ATF3 induction and AMPK activation. ATF3 knockdown reversed these effects, while AMPK activation replicated berberine's benefits.", "population_specificity": "LPS-stimulated SW982 human synovial cell line and collagen-induced arthritis (CIA) mouse model.", "effective_dosage": "Not specified (intraperitoneal administration in mice).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:50.156943+00:00"}
{"study_id": 3524, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the antibacterial mechanism of Berberine (BBR) against the community-associated MRSA strain USA300 LAC and its potential synergy with Oxacillin.", "results_summary": "BBR compromised the cell wall integrity of USA300 LAC by inhibiting the tarO gene, suppressing wall teichoic acid (WTA) biosynthesis, and upregulating lytic enzymes LytM and SsaA, leading to peptidoglycan hydrolysis. Additionally, BBR synergistically enhanced the antibacterial effect of Oxacillin against USA300 LAC.", "population_specificity": "In vitro study on the MRSA strain USA300 LAC.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Synergistic effect with Oxacillin mentioned; no other interactions noted.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:50.885340+00:00"}
{"study_id": 3526, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the association between telomerase activity (RTA) and metabolites/metabolic pathways in HCT 116 colorectal cancer cells treated with berberine.", "results_summary": "Berberine treatment impacted RTA in HCT 116 cells, correlating with 14 metabolites (positively) and 2 metabolites (negatively). Glutamic acid was consistently linked to RTA, and four metabolic pathways involving glutamic acid/glutamine were identified as majorly affected.", "population_specificity": "Colorectal cancer cell line HCT 116.", "effective_dosage": "10.54 \u00b5g/mL.", "study_duration": "Not specified (cells harvested at different time points).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:50.982495+00:00"}
{"study_id": 3527, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers sought to determine whether berberine hydrochloride (BBH) could inhibit Ostreid herpesvirus 1 (OsHV-1) infection in blood clams (Anadara broughtonii).", "results_summary": "A 3 mg/L BBH bath immersion significantly suppressed OsHV-1 replication in blood clams, reduced viral gene expression early in infection, and increased survival rates to 46.67% compared to 100% mortality in untreated clams.", "population_specificity": "Blood clams (Anadara broughtonii) infected with OsHV-1.", "effective_dosage": "3 mg/L (bath immersion).", "study_duration": "Up to 96 hours post-infection.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:51.509575+00:00"}
{"study_id": 3529, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to explore the mechanism of action of berberine against Streptococcus suis meningitis by identifying potential targets and signaling pathways.", "results_summary": "Berberine showed protective effects against S. suis meningitis by regulating inflammatory response and oxidative stress, with key targets including TLR4, FN1, SOD1, and CAT. Molecular docking confirmed strong binding activity between berberine and TLR4/FN1.", "population_specificity": "Humans and pigs (in vitro/computer-based analysis, not clinical trial).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:56.385312+00:00"}
{"study_id": 3528, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate Berberine's role in modulating intestinal microbiota and its potential therapeutic effects on metabolic disorders and inflammatory diseases.", "results_summary": "Berberine promotes beneficial bacteria growth (e.g., Bacteroides, Bifidobacterium, Lactobacillus) and reduces harmful bacteria (e.g., Escherichia coli). It improves blood glucose levels, lipid profiles, and reduces chronic inflammation, particularly when combined with probiotics, and shows promise in treating inflammatory intestinal disorders.", "population_specificity": "Clinical and preclinical studies (specific population not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:56.660408+00:00"}
{"study_id": 3531, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the efficacy and underlying mechanisms of Berberine (BBR) in treating recurrent Clostridioides difficile infection (rCDI) using mouse and organoid models.", "results_summary": "BBR treatment reduced infection severity, improved survival rates, alleviated intestinal epithelial damage, suppressed inflammatory pathways, and reshaped gut microbiota by increasing beneficial bacteria and short-chain fatty acids.", "population_specificity": "Vancomycin-dependent rCDI mouse model and intestinal organoids.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:57.498723+00:00"}
{"study_id": 3530, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether berberine's lipid-lowering effects are linked to its regulation of intestinal microbiota, particularly BSH-producing bacteria.", "results_summary": "Berberine supplementation significantly reduced hepatic triglyceride and cholesterol levels, downregulated lipogenesis and proinflammatory cytokines, and increased beneficial bacteria abundance, particularly BSH-producing strains. However, combining berberine with antibiotics diminished these benefits, suggesting microbiota-dependent mechanisms.", "population_specificity": "Zebrafish (Danio rerio) fed experimental diets.", "effective_dosage": "Not specified", "study_duration": "30 days", "interactions": "Antibiotic cocktail reduced berberine's efficacy.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:58.278484+00:00"}
{"study_id": 3533, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects and mechanisms of berberine combined with JPYSHZF on obese PCOS rats, focusing on hormone levels, glucose/lipid metabolism, and ovarian function.", "results_summary": "Berberine with JPYSHZF improved sex hormone balance, reduced lipid levels, enhanced glucose metabolism, and activated the PI3K/AKT pathway, ameliorating PCOS-like symptoms in obese rats.", "population_specificity": "Obese rats modeled for polycystic ovary syndrome (PCOS).", "effective_dosage": "Not specified", "study_duration": "28 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:58.879651+00:00"}
{"study_id": 3532, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the neuroprotective effects of berberine in animal models of ischemic stroke and elucidate its potential mechanisms of action.", "results_summary": "Berberine significantly reduced infarct volume, improved neurological function, and exhibited anti-inflammatory, antioxidant, anti-apoptotic, and neuroregenerative effects in preclinical models of ischemic stroke.", "population_specificity": "Animal models of focal cerebral ischemia", "effective_dosage": "10 mg/kg to 300 mg/kg", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:58.949859+00:00"}
{"study_id": 3535, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to identify and evaluate berberine-derived compounds for their ability to inhibit human adenovirus (HAdV) replication and explore their antiviral mechanisms.", "results_summary": "Berberine and its analogs demonstrated anti-HAdV activity by inhibiting viral replication through downregulation of the MAPK signaling pathway, particularly ERK activation. 13-methylberberine chloride showed the highest selectivity among tested compounds.", "population_specificity": "In vitro study (no human or animal subjects specified).", "effective_dosage": "Low-micromolar range (specific amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:59.818720+00:00"}
{"study_id": 3534, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Berberine (BBR) enhances the therapeutic effects of Sorafenib (SOR) in hepatocellular carcinoma (HCC) and to elucidate the underlying mechanisms.", "results_summary": "BBR enhanced SOR's proliferation-inhibitory effects, apoptosis, and ROS generation in vitro and in vivo, with the synergistic effect dependent on AMPK activation and mTOR pathway inhibition. BBR showed a stronger synergistic effect with SOR compared to metformin (MET).", "population_specificity": "BEL-7402 and Huh7 cell lines, and tumor xenograft models (no human subjects).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "Synergistic interaction with Sorafenib noted; no other interactions mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:00.661718+00:00"}
{"study_id": 3536, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of berberine-loaded nanoliposomes in targeting and treating glioblastoma by enhancing solubility, bioavailability, and therapeutic impact.", "results_summary": "The study found that berberine-loaded nanoliposomes significantly disrupted glioblastoma cell metabolism, induced autophagy and apoptosis, and suppressed the MAPK signaling pathway, leading to potent anti-cancer effects. The formulation demonstrated high loading efficiency, optimal particle size, and controlled release over 48 hours.", "population_specificity": "U-87 glioblastoma cells (in vitro study)", "effective_dosage": "Not specified", "study_duration": "48 hours (sustained release experiment)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:04.709408+00:00"}
{"study_id": 3537, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to identify and elucidate the direct molecular targets of berberine to better understand its multifaceted pharmacological mechanisms.", "results_summary": "The study identified 13 molecular targets of berberine, including FtsZ, QacR, BmrR, PLA2, RamR, NEK7, and MET, through co-crystal structure analysis, target fishing, molecular docking, and SPR. These findings provide a theoretical foundation for exploring berberine's diverse pharmacological activities, such as antibacterial, anti-inflammatory, antioxidant, and hypoglycemic effects.", "population_specificity": "Not specified (in vitro and molecular analysis)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:05.465652+00:00"}
{"study_id": 3538, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine Berberine's effects on metabolic and bone health in ovariectomized rats as a model for postmenopausal conditions.", "results_summary": "Berberine treatment showed dose-dependent improvements in metabolic and bone parameters, including reduced glucose, insulin resistance, lipid levels, inflammation, oxidative stress, and bone degradation markers, while increasing beneficial markers like oestradiol and HDL-C.", "population_specificity": "Ovariectomized adult female rats (postmenopausal model).", "effective_dosage": "50, 100, and 200 mg/kg/day.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:06.031916+00:00"}
{"study_id": 3539, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Berberine (BBR) protects mice from obesity-induced skeletal muscle atrophy and to explore the underlying molecular mechanism involving the mitophagy receptor FUNDC1.", "results_summary": "BBR treatment improved grip strength, muscle function, and reduced obesity-related skeletal muscle atrophy and apoptosis. It also promoted autophagy and increased FUNDC1 protein expression, with FUNDC1 RNA interference attenuating BBR's effects.", "population_specificity": "C57BL/6 mice fed a high-fat diet and C2C12 myotubes.", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:06.798303+00:00"}
{"study_id": 3541, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the antibacterial mode of action of berberine (Ber) combined with antibiotics (Ber-Ab) under blue light irradiation against Staphylococcus aureus, including MRSA and MSSA strains.", "results_summary": "Blue light-activated Ber-Ab combinations generated substantial ROS, causing oxidative stress that severely damaged bacterial membranes (90% in MRSA, 40% in MSSA) and DNA (\u224850% in both strains). The treatment also reduced S. aureus pathogenicity by impairing motility and inhibiting key virulence factors.", "population_specificity": "Staphylococcus aureus strains (MRSA and MSSA) in a laboratory setting.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:08.273109+00:00"}
{"study_id": 3540, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine Berberine's inhibitory effects on drug-resistant fungi, particularly Candida albicans, and its mechanism of action involving iron acquisition disruption.", "results_summary": "Berberine inhibited azole-resistance gene expression, reduced cell adhesion, disrupted biofilm formation, and impaired fungal iron acquisition, leading to mitochondrial dysfunction and fungal death. The study identified Ftr1 as a key target in this process.", "population_specificity": "In vitro study on drug-resistant Candida albicans (no human or animal subjects mentioned).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:08.408031+00:00"}
{"study_id": 3542, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the molecular mechanisms by which berberine (BBR) exerts its therapeutic effects in diabetic nephropathy (DN), specifically focusing on the LOC102549726/EGF/FOXO1 axis.", "results_summary": "The study found that BBR reduces podocyte migration and apoptosis in DN by targeting the LOC102549726/EGF/FOXO1 pathway, lowering the levels of these molecules in both DN rats and podocytes under high glucose conditions.", "population_specificity": "Diabetic nephropathy (DN) model rats and podocytes subjected to high glucose conditions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:08.626580+00:00"}
{"study_id": 3543, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate Berberine's protective effect against kainic acid-induced epileptic seizures in mice and explore its mechanism via gut microbiota and lipid metabolism.", "results_summary": "Berberine significantly reduced acute epileptic seizures and hippocampal neuron damage in mice, likely by altering gut microbiota (increasing Bacteroidetes and Alloprevotella) and regulating short-chain fatty acids and lipid metabolites in the colon and hippocampus.", "population_specificity": "KA-induced seizure model in mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:08.705511+00:00"}
{"study_id": 3545, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to identify target genes of berberine (BBR) associated with Alzheimer's disease (AD) therapy and explore its protective mechanisms.", "results_summary": "The study found that BBR reduced mRNA and protein expression of APP and presenilin 1 while increasing PPARG expression, blocking APP processing and amyloid plaque formation. It also inhibited the NF-\u03baB pathway, reducing neuroinflammation in both in vitro and in vivo models.", "population_specificity": "AD mice model and BV2/C8-D1A cell lines", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:13.121358+00:00"}
{"study_id": 3547, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the pharmacological mechanism of Berberine (BBR) in treating chronic atrophic gastritis (CAG) using molecular biology and multi-omics approaches.", "results_summary": "BBR improved CAG by reducing inflammation, maintaining gastric mucosal integrity, and repairing tissue. It regulated the MAPK pathway, metabolic disorders, and gut microbiota, targeting specific genes and metabolites.", "population_specificity": "Animal model (CAG-induced)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:13.773941+00:00"}
{"study_id": 3546, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate Berberine's effects on breast cancer stem cell proliferation, miRNA and IL-6 levels, and depressive-like behaviors in mice with breast cancer.", "results_summary": "Berberine inhibited mammosphere formation and CSC proliferation, upregulated tumor-suppressive miRNAs (miR-let-7c, miR-34a, miR-145), and reduced serum IL-6 levels, but did not significantly affect depressive-like behaviors or tumor tissue IL-6.", "population_specificity": "Murine 4T1 and human MDA-MB-231 breast cancer cell lines, and female BALB/c mice with induced mammary carcinoma.", "effective_dosage": "75 \u03bcM in vitro; oral administration in vivo (specific dosage not stated).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:15.336147+00:00"}
{"study_id": 3548, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the mechanisms by which Berberine (BBR) inhibits cell senescence and reduces inflammation linked to atherosclerosis.", "results_summary": "BBR reduced inflammation associated with senescence in atherosclerosis via the RXR\u03b1/PPAR\u03b3/NEDD4 pathway, promoted ubiquitination of the GATA4/p62 complex, and inhibited SASP-related protein production. The anti-aging effects of BBR were negated when macrophage-specific RXR\u03b1 was knocked down.", "population_specificity": "ApoE[Formula: see text] mice fed a high-fat diet and RAW264.7/peritoneal macrophage-derived foam cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:15.897998+00:00"}
{"study_id": 3551, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Berberine inhibits hepatocellular carcinoma (HCC) progression by modulating HIF-1\u03b1 expression.", "results_summary": "Berberine reduced proliferation, migration, and invasion of HepG2 cells while increasing apoptosis and decreasing glycolysis-related proteins. It also inhibited tumor growth in nude mice, though CoCl2-induced HIF-1\u03b1 expression attenuated its anti-tumor effects.", "population_specificity": "HepG2 cells (in vitro) and nude mice with xenograft tumors (in vivo).", "effective_dosage": "100 \u03bcmol/L (in vitro).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:17.021814+00:00"}
{"study_id": 3552, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the neuroprotective potential of Berberine (BBR) in a thioacetamide-induced hepatic encephalopathy (HE) rat model, focusing on its effects on glial activation and NLRP3 inflammasome signaling.", "results_summary": "BBR treatment improved behavioral abnormalities, reduced systemic ammonia levels, restored blood-brain barrier integrity, inhibited NLRP3 inflammasome markers, reduced glial cell activation, and preserved neuronal integrity in the HE rat model.", "population_specificity": "Thioacetamide-induced hepatic encephalopathy rat model", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:17.341836+00:00"}
{"study_id": 3549, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether berberine (BBR) could ameliorate coronary endothelial cell injury in Kawasaki disease (KD) by regulating the complement and coagulation cascade.", "results_summary": "The study found that BBR treatment reduced the expression of key proteins (C1QC, KNG1, C1S, C4BPA) involved in the complement and coagulation cascade, suggesting a potential therapeutic role in mitigating coronary injury in KD. Bioinformatics analysis supported these findings, linking BBR's effects to specific pathways.", "population_specificity": "Human coronary artery endothelial cells (HCAEC) treated with serum from healthy children and KD patients.", "effective_dosage": "20 mmol/L BBR", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:17.674416+00:00"}
{"study_id": 3550, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the cytotoxic effects and mechanisms of action of berberine chloride (BBC) in combination with a copper(II) complex in cancer and non-cancer cell lines.", "results_summary": "The combination of BBC and the copper(II) complex showed enhanced cytotoxic effects in cancer cells (IC50 = 9.3 \u00b1 1.5 \u03bcM) compared to BBC alone (IC50 = 48.3 \u00b1 2.4 \u03bcM). The treatment induced cell cycle arrest in the G2 phase and activated both intrinsic and extrinsic apoptotic pathways, as well as necroptosis via the RIPK3-MLKL pathway.", "population_specificity": "Cancer (MDA-MB-231 VIM RFP) and non-cancer (MCF-10A) cell lines.", "effective_dosage": "IC50 values: 48.3 \u00b1 2.4 \u03bcM for BBC alone, 9.3 \u00b1 1.5 \u03bcM for the combination.", "study_duration": "24-hour incubation.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:19.889329+00:00"}
{"study_id": 3554, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the molecular mechanism by which Berberine inhibits the malignant progression of non-small cell lung cancer (NSCLC), focusing on the SPC25/NUF2 axis.", "results_summary": "Berberine inhibited NSCLC cell growth, invasion, and glycolysis by reducing SPC25 expression and disrupting the SPC25/NUF2 interaction, which was confirmed in both in vitro and in vivo experiments.", "population_specificity": "NSCLC cells (A549 and H1299) and xenograft tumor models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:22.292967+00:00"}
{"study_id": 3553, "supplement_id": 921, "safety_score": "80", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to investigate the potential of berberine and its derivatives as allosteric activators of the AMPK pathway for treating diabetes.", "results_summary": "Berberine and its derivatives showed potential binding affinity at the allosteric site of AMPK \u03b1- & \u03b2-subunit, similar to standard activators, but interactions with the \u03b3-subunit were less stable. ADMET predictions suggested these derivatives are safe, warranting further investigation.", "population_specificity": "Not specified (in vitro or computational study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:22.748545+00:00"}
{"study_id": 3555, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of calcium alginate-coated nanovesicles loaded with berberine (Ber@MVs-CA) for targeted oral treatment of ulcerative colitis and enteritis.", "results_summary": "Ber@MVs-CA demonstrated pH-responsive drug release, effective targeting of inflammatory macrophages, and sustained retention in the colon. It attenuated inflammatory responses, modulated macrophage polarization, and inhibited oxidative stress in both in vitro and in vivo models.", "population_specificity": "Mice and chickens (Clostridium perfringens-induced enteritis model).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:23.646867+00:00"}
{"study_id": 3556, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the synergistic anti-tumor efficacy of berberine-loaded mesoporous polydopamine nanoparticles (BER-MPDA) combined with near-infrared laser irradiation for multimodal cancer therapy.", "results_summary": "BER-MPDA demonstrated enhanced tumor inhibition through combined chemotherapy and photothermal therapy, with superior results compared to monotherapy, attributed to improved cellular uptake and dual cytotoxic effects.", "population_specificity": "In vitro and in vivo models (specific human or animal details not provided).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:24.126211+00:00"}
{"study_id": 3559, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether berberine (BR) could attenuate cerulein-induced acute pancreatitis (AP) by modulating AMPK activity, oxidative stress, and inflammation in a mouse model.", "results_summary": "Berberine treatment significantly reduced plasma amylase and lipase levels, improved histopathological features, suppressed neutrophil infiltration, decreased proinflammatory cytokines (IL-6, IL-1\u03b2, TNF-\u03b1), and mitigated oxidative-nitrosative stress by activating Nrf2 signaling and AMPK expression.", "population_specificity": "Cerulein-induced acute pancreatitis mouse model.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:26.199432+00:00"}
{"study_id": 3558, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the antimicrobial properties and mechanisms of berberine against MRSA and its potential to enhance antibiotic therapy.", "results_summary": "Berberine showed variable but significant inhibitory effects on 50 clinical MRSA strains and synergistic effects with amikacin in 6 strains. It disrupted MRSA cell wall integrity and targeted multiple bacterial survival pathways.", "population_specificity": "50 clinical MRSA strains", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "Synergistic effect with amikacin noted", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:26.326553+00:00"}
{"study_id": 3557, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether Berberine (BBR) could protect against AGEs-induced ferroptosis in keratinocytes and elucidate its molecular mechanisms, particularly involving NRF2 activation.", "results_summary": "BBR significantly protected cell viability, reduced oxidative stress markers (MDA, ROS, iron levels), and upregulated protective proteins (GPX4, FTL, FTH, NRF2) in AGEs-treated keratinocytes and diabetic mice, suggesting its antiferroptotic effects are partly mediated by NRF2 activation.", "population_specificity": "HaCaT cells (in vitro) and db/db diabetic mice (in vivo).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:26.614032+00:00"}
{"study_id": 3560, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to elucidate the metabolic mechanisms by which berberine exerts therapeutic effects on ulcerative colitis (UC) in a rat model.", "results_summary": "Berberine modulated metabolic disturbances in UC rats, restoring levels of key metabolites linked to amino acid, glutathione, and pyrimidine metabolism pathways, suggesting potential plasma biomarkers for UC treatment.", "population_specificity": "DSS-induced UC model in rats", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:27.592827+00:00"}
{"study_id": 3562, "supplement_id": 921, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether berberine (BBR) could activate GSDME-mediated pyroptosis, improve the immunosuppressive tumor microenvironment, and enhance anti-tumor immunity.", "results_summary": "Berberine induced pyroptosis via the caspase-3/GSDME pathway, improved immune cell activity (DCs maturation, macrophage polarization), and demonstrated anti-tumor effects in 4T1 orthotopic model mice, including inhibition of breast cancer lung metastasis.", "population_specificity": "4T1 orthotopic model mice and zebrafish embryos (for toxicity evaluation).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:31.276476+00:00"}
{"study_id": 3561, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether a berberine derivative (B68) could induce tumor cell senescence while reducing PD-L1 expression to counteract immune evasion and enhance antitumor immunity.", "results_summary": "B68 effectively induced tumor cell senescence by targeting BMI1 and degraded PD-L1 by targeting CSN5, disrupting immunosuppressive PD-1/PD-L1 interactions and enabling immune clearance of senescent cells. It also showed synergistic effects with anti-CTLA4 therapy, enhancing antitumor immunity and triggering protective responses by dendritic and CD8+ T cells.", "population_specificity": "Tumor cells (in vitro or preclinical model, not specified for human subjects).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:32.011748+00:00"}
{"study_id": 3564, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Coptis chinensis extract and berberine could modulate lower esophageal sphincter (LES) relaxation, potentially offering a therapeutic option for esophageal motility disorders like achalasia.", "results_summary": "Both C. chinensis extract and berberine induced significant, concentration-dependent relaxation of the LES, primarily through potassium channel activation, as evidenced by reduced effects with TEA inhibition.", "population_specificity": "Not specified (in vitro or ex vivo study, likely animal or tissue-based).", "effective_dosage": "Different concentrations tested (specific amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:33.024048+00:00"}
{"study_id": 3563, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate Berberine's impact on atherosclerosis (AS) and non-alcoholic fatty liver disease (NAFLD) by identifying key genes and pathways involved and validating its efficacy in an animal model.", "results_summary": "Berberine significantly reduced lipid deposits and inflammatory markers in liver and aortic tissues by regulating genes like MNDA, PIM2, DUSP6, CCL3, C5AR1, and FPR1, suggesting its mechanism involves inflammation control. The findings indicate potential clinical benefits for AS and NAFLD.", "population_specificity": "ApoE-/- mice fed a high-fat diet.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:33.144088+00:00"}
{"study_id": 3565, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate Berberine's antifungal properties, mechanisms, and potential as an antifungal therapy and antibiotic adjuvant.", "results_summary": "Berberine demonstrated broad-spectrum antifungal activity through multiple mechanisms, including targeting fungal mitochondria, cell membranes, and cell walls, while also modulating host defenses. It showed synergistic effects with conventional antifungal drugs, enhancing its potency against drug-resistant infections and biofilms.", "population_specificity": "Not specified (in vitro and in vivo studies, but no specific human population mentioned).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Mentioned interaction with conventional antifungal drugs, enhancing intracellular accumulation of Berberine.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:34.585312+00:00"}
{"study_id": 3566, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Berberine (BBR) alleviates ischemic neuronal injury by reinforcing NSF activity to enhance autophagosome-lysosome fusion.", "results_summary": "BBR significantly restored NSF activity, improved autophagosome-lysosome fusion, and alleviated ischemic injury in neurons. NSF knockdown counteracted BBR's neuroprotective effects, while NSF overexpression synergistically enhanced its benefits.", "population_specificity": "Rat model of ischemic stroke and HT22 neuronal cells subjected to oxygen-glucose deprivation (OGD).", "effective_dosage": "100 mg/Kg/d (rats, intraperitoneal), 90 \u03bcM (HT22 neurons).", "study_duration": "3 days (rats), 12 hours (HT22 neurons).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:36.202096+00:00"}
{"study_id": 3567, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the interaction between a novel platinum(II) complex with a berberine derivative and G-quadruplex DNA, as well as its antiproliferative effects on tumor cells.", "results_summary": "The study found that the berberine-derived platinum(II) complex (Pt1) interacted favorably with G-quadruplex DNA, particularly the bcl-2 G-quadruplex, and demonstrated antiproliferative activity in tumor cells (HeLa, A549, T24), inducing apoptosis in HeLa cells.", "population_specificity": "Tumor cell lines (HeLa, A549, T24)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:37.930012+00:00"}
{"study_id": 3568, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Berberine could enhance autophagy and mitigate cisplatin-induced acute kidney injury by reducing oxidative stress, inflammation, and apoptosis.", "results_summary": "Berberine upregulated autophagy markers (pS486-AMPK, pS638-ULK1, Beclin-1) and reduced oxidative stress (lower MDA, higher SOD), inflammation (downregulated HMGB1, RAGE, NF-\u03baB, IL-6), and apoptosis (increased Bcl-2, decreased Bax), preserving kidney function and histopathology. The protective effects were nullified by the autophagy inhibitor 3-MA, confirming Berberine's role in autophagy promotion.", "population_specificity": "Cisplatin-induced acute kidney injury model (likely preclinical, e.g., animal study, based on abstract).", "effective_dosage": "Not specified in abstract.", "study_duration": "Not specified in abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:38.242265+00:00"}
{"study_id": 3569, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the synergistic effect of berberine (BBR) and atmospheric pressure plasma (APP) on inducing apoptosis in non-small cell lung cancer (NSCLC) cells and its underlying mechanisms.", "results_summary": "The combination of BBR and APP synergistically induced apoptosis in NSCLC cells by increasing ROS accumulation, downregulating EGFR expression, and inhibiting the AKT/ERK signaling pathways. It also inhibited cell migration and epithelial-to-mesenchymal transition (EMT).", "population_specificity": "Non-small cell lung cancer (NSCLC) cells in vitro.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:39.554197+00:00"}
{"study_id": 3570, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to systematically assess the efficacy and safety of Berberine (BBR) for treating Type 2 diabetes mellitus (T2DM) through a meta-analysis of randomized controlled trials.", "results_summary": "Berberine alone significantly reduced fasting plasma glucose, postprandial blood glucose, and lipid markers. When combined with hypoglycemic drugs, it further improved glycemic control, insulin resistance, and inflammatory markers.", "population_specificity": "4,150 participants with Type 2 diabetes mellitus (T2DM).", "effective_dosage": "0.9-1.5 g/d.", "study_duration": "1-3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:40.923402+00:00"}
{"study_id": 3571, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to identify the specific protein targeted by berberine that contributes to its hypoglycemic effects and elucidate the mechanism behind its action.", "results_summary": "The study identified TIGAR as a direct target protein of berberine, revealing that berberine attenuates the conversion of fructose-2,6-bisphosphate to fructose-6-phosphate, demonstrating a novel mechanism for its hypoglycemic effects.", "population_specificity": "Not specified (in vitro or animal model implied, but not explicitly stated).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:41.466848+00:00"}
{"study_id": 3573, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the relationship between berberine and tuft cells in DSS-induced colitis and determine its mechanism of action.", "results_summary": "Berberine significantly ameliorated DSS-induced colitis by regulating type 2 innate immune lymphocytes (ILC2) and Th2 immune cells via tuft cells, with its effect partially dependent on the bitter taste signaling pathway.", "population_specificity": "DSS-induced colitis model (animal study, exact species not specified).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:42.633321+00:00"}
{"study_id": 3572, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether liposome-delivered berberine (Lipo@BBR) could enhance photodynamic therapy (PDT) efficacy in A549 lung cancer spheroid cells by improving solubility and bioavailability.", "results_summary": "The study found that Lipo@BBR improved PDT efficiency, reducing tumor spheroid volume after five PDT sessions (total light dose: 25 J/cm\u00b2) with an IC50 of 10 \u00b1 0.5 \u03bcg/mL. It also increased the BAX/BCL2 ratio, promoting cell death.", "population_specificity": "A549 lung cancer spheroid cells (in vitro model).", "effective_dosage": "10 \u00b1 0.5 \u03bcg/mL (IC50 concentration for PDT).", "study_duration": "Five sessions of PDT fractionation (duration per session not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:43.594220+00:00"}
{"study_id": 3576, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the mechanism of action of berberine in treating rheumatoid arthritis (RA) by mediating exosomal contents and regulating lipid-related biological pathways.", "results_summary": "Berberine promoted apoptosis in RA-FLS cells and modulated 11 lipid core biomarkers associated with RA, influencing lipid metabolism pathways, PPAR\u03b3-NF-\u03baB complex binding, and inflammatory responses. The study suggests berberine's therapeutic potential in RA by targeting exosomal regulation.", "population_specificity": "RA-FLS cells (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:45.995843+00:00"}
{"study_id": 3574, "supplement_id": 921, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "To evaluate the in vitro killing effect of water-soluble berberine against ocular Demodex folliculorum and compare its efficacy with other treatments.", "results_summary": "0.2% berberine significantly inhibited the survival distribution and survival time of Demodex in vitro compared to the control group (P < 0.001). The study also noted good subjective tolerability and safety in a mouse model.", "population_specificity": "Demodex folliculorum collected from patients' eyelashes.", "effective_dosage": "0.2% berberine.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:46.037271+00:00"}
{"study_id": 3577, "supplement_id": 921, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to develop and evaluate a surface-modified berberine hydrochloride-loaded liposomal in-situ nasal gel for improved brain targeting, specifically for Alzheimer's disease management.", "results_summary": "The study found that the liposomal in-situ gel significantly enhanced brain targeting (Cmax of 93.50 ng/mL) and improved pharmacodynamic parameters (reduced escape latency and path length) in a neurodegeneration model. Histopathological assessment confirmed the formulation's safety for intranasal administration.", "population_specificity": "Male Wistar rats with trimethyl tin-induced neurodegeneration.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:47.750194+00:00"}
{"study_id": 3578, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to elucidate how berberine (BBR) alleviates septic cardiomyopathy (SCM) by investigating its effects on mitochondrial protection and the Notch1 signaling pathway.", "results_summary": "BBR improved cardiac function, ATP levels, and mitochondrial structure in SCM rats and H9C2 cells, with these effects linked to upregulation of Notch1 signaling. Inhibition of Notch1 reversed BBR's benefits, confirming its mechanistic role.", "population_specificity": "Septic cardiomyopathy rat model (CLP-induced) and LPS-injured H9C2 cardiomyocytes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:48.942568+00:00"}
{"study_id": 3579, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to summarize berberine's antitumor effects, its impact on cellular and molecular pathways, and the potential of nanotechnology and combination therapies to enhance its efficacy in lung cancer treatment.", "results_summary": "Berberine exhibits antitumor effects by targeting apoptosis, autophagy, cell cycle arrest, migration, and metastasis, but its clinical application is limited by low bioavailability and poor solubility. Nanotechnology and combination therapies may improve its efficacy.", "population_specificity": "Not specified (general focus on lung cancer).", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:49.422477+00:00"}
{"study_id": 3580, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether Berberine (BBR) mitigates esophageal injury in GERD by targeting TAS2R38 and elucidating its underlying molecular mechanisms.", "results_summary": "BBR significantly improved esophageal pathology in GERD rats, reduced inflammation in human esophageal epithelial cells, suppressed proinflammatory factors, and enhanced barrier proteins by modulating MAPK/NF-\u03baB pathways. Its effects were diminished upon TAS2R38 knockdown, confirming its mechanistic role.", "population_specificity": "GERD rat model and human esophageal epithelial cells (HEECs).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:50.507215+00:00"}
{"study_id": 3581, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether berberine inhibits colon-liver metastasis in an animal model and elucidate its underlying mechanisms, particularly focusing on the TGF-\u03b2 signaling pathway.", "results_summary": "Berberine significantly reduced liver tumor nodules, activated E-cadherin, suppressed mesenchymal markers (vimentin, Snail, TGF-\u03b2), lowered inflammatory cytokines, and inhibited migration and invasion in resistant cancer cells, primarily via TGF-\u03b2 signaling inhibition.", "population_specificity": "Balb/c mice with implanted CT26 colon carcinoma and 5-fluorouracil-resistant human colon cancer cells (HCT116/R).", "effective_dosage": "100 mg/kg (oral administration).", "study_duration": "21 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:52.117833+00:00"}
{"study_id": 3582, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether encapsulating Berberine in a PEG-PLGA nanocarrier (NPBer) improves its delivery efficiency and antitumor efficacy in colorectal cancer (CRC) cells.", "results_summary": "NPBer showed enhanced uptake by HCT116 CRC cells, stronger inhibition of cell proliferation, and improved in vivo antitumor effects compared to free Berberine. RNA-Seq revealed that NPBer enhanced mitochondrial autophagy, regulated inflammatory mediators, and inhibited key signaling pathways like Notch, leading to increased apoptosis and tumor suppression.", "population_specificity": "HCT116 colorectal cancer cells (in vitro and in vivo models).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:52.990402+00:00"}
{"study_id": 3584, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to demonstrate that combining Berberine hydrochloride (BH) and Matrine (MT) in liposomes could enhance therapeutic effects and minimize side effects for potential cancer treatment.", "results_summary": "BH-MT-LP showed superior anti-tumor activity against MDA-MB-231, HepG-2, and HGC-27 cells in vitro, promoting apoptosis by blocking the G1 phase and inducing cell death. The controlled release from liposomes further enhanced BH's therapeutic efficacy.", "population_specificity": "In vitro cancer cell lines (MDA-MB-231, HepG-2, HGC-27)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:55.053916+00:00"}
{"study_id": 3583, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop a portable sensing platform (STSHSP) for accurate, real-time detection of berberine in environmental and biological samples to monitor its accumulation and reduce harm from abuse.", "results_summary": "The study successfully developed a hand-held sensor (STSHSP) with high linearity (R\u00b2 = 0.9997) and a detection limit of 28.32 ng/mL for berberine, demonstrating stability and accuracy in real-world samples like river water, urine, and traditional Chinese medicine.", "population_specificity": "Environmental water samples, urine, traditional Chinese medicine, and its preparations.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:55.485412+00:00"}
{"study_id": 181173, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of high- and low-compression HIIT with or without berberine on inflammatory markers and insulin resistance in middle-aged men with overweight/obesity and prediabetes.", "results_summary": "Berberine alone significantly reduced fasting blood glucose and insulin resistance (HOMA-IR) compared to baseline. However, adding berberine to exercise programs did not provide additional benefits beyond exercise alone.", "population_specificity": "Middle-aged men with overweight or obesity and prediabetes (FBG 110-180 mg/dL).", "effective_dosage": "Approximately 1000 mg daily.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:56.716799+00:00"}
{"study_id": 181175, "supplement_id": 921, "safety_score": "80", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to review the potential of natural products, including Berberine, as anti-NAFLD agents by exploring their mechanisms, targets, and clinical potential.", "results_summary": "The study highlights Berberine's anti-NAFLD effects through regulation of lipid metabolism, insulin resistance, oxidative stress, and inflammation-related pathways, with clinical phase IV studies indicating its therapeutic promise.", "population_specificity": "Patients with non-alcoholic fatty liver disease (NAFLD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:57.456683+00:00"}
{"study_id": 181176, "supplement_id": 921, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential benefits of Berberine Phytosome\u2122 supplementation on metabolic profiles in subjects with impaired fasting blood glucose (IFG).", "results_summary": "Berberine significantly improved glycemia, total cholesterol, triglycerides, insulin levels, ApoB/ApoA ratio, and reduced visceral adipose tissue and fat mass compared to placebo. No adverse events were reported.", "population_specificity": "Overweight subjects (28 females, 21 males) with impaired fasting blood glucose.", "effective_dosage": "550 mg/tablet, 2 tablets/day (total 1,100 mg/day).", "study_duration": "60 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:59.420528+00:00"}
{"study_id": 181177, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of food-derived substances, including berberine, in treating non-alcoholic fatty liver disease (NAFLD).", "results_summary": "The study found that berberine, among other substances, led to a decrease in liver fat amounts, contributing to improvements in NAFLD therapy. The abstract highlights its potential as a significant adjuvant treatment.", "population_specificity": "Patients with non-alcoholic fatty liver disease (NAFLD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:59.765218+00:00"}
{"study_id": 181178, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to summarize recent findings on Berberine's effects on inflammation, gut microbes, macrophage polarization, and immune responses, particularly in ulcerative colitis and cancer.", "results_summary": "The study highlights Berberine's anti-inflammatory, antibacterial, antioxidant, anti-obesity, and antitumor properties, but notes that underlying mechanisms require further exploration. It also discusses its potential therapeutic efficacy in ulcerative colitis and cancer.", "population_specificity": "Not specified (general review of existing research).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:02.704147+00:00"}
{"study_id": 181179, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore how berberine, as an activator of AMP-activated kinase, can increase the expression of nicotinamide phosphoribosyltransferase, thereby boosting NAD+ synthesis and Sirt1 activity.", "results_summary": "The study found that berberine enhances the expression of nicotinamide phosphoribosyltransferase, a rate-limiting enzyme for NAD+ synthesis, which in turn supports Sirt1 activity, potentially promoting healthspan. The abstract suggests berberine's role in a broader nutraceutical strategy to activate Sirt1 through complementary mechanisms.", "population_specificity": "Not specified (general cellular and biochemical mechanisms discussed)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:04.303753+00:00"}
{"study_id": 181180, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to compare the plasma appearance rates of berberine after oral ingestion of berberine (500 mg) versus dihydroberberine (100 mg and 200 mg).", "results_summary": "The study measured plasma concentrations of berberine, glucose, and insulin at multiple time points after ingestion, but the abstract does not provide specific results on efficacy or comparative outcomes between the doses.", "population_specificity": "Five healthy males (26 \u00b1 2.6 years; 184.2 \u00b1 11.6 cm; 91.8 \u00b1 10.1 kg; 17.1 \u00b1 3.5% fat).", "effective_dosage": "500 mg berberine (B500), 100 mg dihydroberberine (D100), and 200 mg dihydroberberine (D200), administered three times daily with meals and once with a standardized test meal.", "study_duration": "Short-term (single-day intervention with four doses).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:06.465745+00:00"}
{"study_id": 181182, "supplement_id": 921, "safety_score": "65", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of Berberine (BBR) in preventing the recurrence of colorectal adenomas through a systematic review and meta-analysis of available data.", "results_summary": "The study found that 1-year and 2-year supplementation with BBR was associated with a lower recurrence rate of colorectal adenoma, though adverse events were more common with BBR than placebo, primarily constipation, which resolved upon discontinuation. No serious adverse events were reported.", "population_specificity": "1076 patients in three randomized controlled clinical trials.", "effective_dosage": "Not specified in the abstract.", "study_duration": "1-year and 2-year supplementation periods.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:06.669749+00:00"}
{"study_id": 181181, "supplement_id": 921, "safety_score": "85", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effectiveness of a bioavailable berberine formulation on insulin resistance, inflammation, lipid metabolism, sex hormone profile, and hyperandrogenism-related symptoms in women with PCOS.", "results_summary": "Berberine significantly improved insulin resistance (HOMA), inflammation (CRP, TNF-\u03b1), lipid metabolism (triglycerides), sex hormone profile (testosterone, SHBG), and hyperandrogenism-related symptoms (acne scores), while also reducing BMI and fat mass. No significant adverse effects on liver, kidney function, or CPK were observed.", "population_specificity": "Normal-overweight women with PCOS and normal menses (n=12, aged 26.6 \u00b1 4.9, BMI 25.3 \u00b1 3.6).", "effective_dosage": "550 mg/tablet, two tablets/day (total 1100 mg/day).", "study_duration": "60 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:07.343399+00:00"}
{"study_id": 181184, "supplement_id": 921, "safety_score": "65", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to review the therapeutic effects and safety profile of berberine, a bioactive alkaloid in goldenseal, based on existing scientific literature.", "results_summary": "The study found that berberine exhibits multiple therapeutic effects, including antimicrobial, anti-inflammatory, and neuroprotective properties, but also noted potential neurotoxic, hepatotoxic, and phototoxic risks.", "population_specificity": "Not specified (literature review of existing studies).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:07.632548+00:00"}
{"study_id": 181174, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of berberine supplementation in improving glycemic parameters and inflammatory markers in adults by analyzing existing meta-analyses.", "results_summary": "Berberine supplementation was found to significantly reduce fasting blood glucose (FBG), postprandial blood glucose (PBG), hemoglobin A1c (HbA1c), and C-reactive protein (CRP) levels, indicating improvements in glycemic control and inflammation. The study concluded that berberine could be effective for these outcomes.", "population_specificity": "Adults", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:08.563006+00:00"}
{"study_id": 181185, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to clarify the effects of berberine supplementation on obesity indices in human subjects by conducting a systematic review and meta-analysis.", "results_summary": "The meta-analysis of 10 studies found that berberine supplementation significantly reduced body mass index (BMI) and waist circumference but not body weight. The results support berberine's use for improving obesity indices.", "population_specificity": "Human subjects (specific demographics not detailed in the abstract).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:09.643022+00:00"}
{"study_id": 181186, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the effects of Berberine on C-reactive protein (CRP) levels in adults through a systematic review and meta-analysis of randomized controlled trials.", "results_summary": "The meta-analysis found that Berberine supplementation significantly reduced serum CRP levels (MD: -0.64 mg/L, 95% CI: -0.67 to -0.61, P < 0.001) without significant heterogeneity, suggesting potential benefits for chronic inflammation, particularly in cardiovascular disease and diabetes patients.", "population_specificity": "Adults, with specific mention of cardiovascular disease and diabetes patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:11.552841+00:00"}
{"study_id": 181187, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to summarize literature on phytochemicals, including berberine, and discuss their effectiveness and therapeutic value for improving acute pancreatitis.", "results_summary": "The study suggests that berberine and other phytochemicals may improve acute pancreatitis symptoms by targeting the balance between apoptosis and necrosis, potentially serving as a valuable addition to standard treatment.", "population_specificity": "Not specified (literature review of existing studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:12.956867+00:00"}
{"study_id": 181188, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the cholesterol-lowering efficacy and vascular protective effects of Berberine and other nutraceuticals in clinical interventional studies.", "results_summary": "The study found that Berberine has mild-to-moderate cholesterol-lowering efficacy, with promising evidence for vascular protective effects, though its impact on cardiovascular outcomes remains uninvestigated.", "population_specificity": "Not specified (general clinical interventional study population)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:13.689544+00:00"}
{"study_id": 181189, "supplement_id": 921, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to assess the safety, tolerability, and efficacy of a nutraceutical supplement containing berberine as part of a lifestyle modification program in overweight individuals with cardio-metabolic syndrome risk factors.", "results_summary": "The study found that the group receiving nutraceutical supplementation (including berberine) showed greater improvements in body mass, fat mass, lipid profiles, and inflammatory markers compared to the diet-only group, with a significant reduction in cardiovascular disease risk score. However, the study could not isolate berberine's specific effects due to the multi-component intervention.", "population_specificity": "Overweight individuals with cardio-metabolic syndrome risk factors.", "effective_dosage": "Not specified", "study_duration": "13 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:15.709939+00:00"}
{"study_id": 181193, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the lipid-lowering effects of Berberine as part of a combination of nutraceuticals for treating dyslipidemia.", "results_summary": "Berberine was found to enhance hepatic uptake of cholesterol, contributing to its lipid-lowering effects when used in combination with other nutraceuticals. The study suggests that such combinations can be effective alternatives to drug treatments for certain patients.", "population_specificity": "Patients in primary cardiovascular disease prevention with mildly added cardiovascular risk and statin-intolerant patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:17.240427+00:00"}
{"study_id": 181192, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to explore the mechanistic interactions of Berberine with other functional agents like coenzyme Q10, astaxanthin, and vitamin D in the context of red yeast rice's health benefits.", "results_summary": "The abstract mentions Berberine as one of the functional agents interacting with red yeast rice, but specific effects or outcomes related to Berberine alone are not detailed. The study highlights red yeast rice's broader benefits, including cholesterol reduction and anti-inflammatory properties, but Berberine's role is not independently evaluated.", "population_specificity": "Not specified (general context of red yeast rice research)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Mentioned as interacting with coenzyme Q10, astaxanthin, vitamin D, folic acid, and policosanol.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:17.243218+00:00"}
{"study_id": 181194, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether berberine, as an AMPK activator, could antagonize TLR4-mediated activation of ERK1/2, thereby reducing the induction of tissue factor (TF) and TNF-\u03b1 in sepsis.", "results_summary": "The study found that berberine, along with other nutraceuticals, showed protective utility in rodent models of sepsis by antagonizing TLR4-mediated signaling pathways, though clinical evaluations were not conducted.", "population_specificity": "Rodent models of sepsis", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:17.646102+00:00"}
{"study_id": 181191, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of a nutraceutical combination containing berberine, policosanol, and red yeast rice (Armolipid Plus\u00ae) on lipid profile through a meta-analysis of randomized clinical trials.", "results_summary": "The meta-analysis found significant improvements in lipid parameters, including reductions in total cholesterol (-9.9%), LDL-c (-13.7%), and triglycerides (-7.0%), and a modest increase in HDL-c (+3.7%). The results were consistent across 11 RCTs involving 3,924 patients.", "population_specificity": "Patients with metabolic syndrome or lipid profile abnormalities (1,970 in the intervention group, 1,954 controls).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:18.179124+00:00"}
{"study_id": 181195, "supplement_id": 921, "safety_score": "75", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate berberine's potential as a natural supplement for improving menopausal symptoms and associated pathologies, focusing on its effects on oxidative stress, lipid metabolism, insulin resistance, and mood.", "results_summary": "The study found that berberine reduces oxidative stress, LDL, triglycerides, and insulin resistance while improving mood, suggesting it may help manage peri- and postmenopausal symptoms effectively.", "population_specificity": "Postmenopausal women", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:19.310828+00:00"}
{"study_id": 181196, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review the efficacy and safety of commonly used nutraceuticals, including Berberine, for cholesterol-lowering effects.", "results_summary": "The abstract does not provide specific findings on Berberine's effects, only mentioning that some nutraceuticals may improve lipid profiles.", "population_specificity": "Not specified (general discussion on hypercholesterolemia patients).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:20.447821+00:00"}
{"study_id": 181197, "supplement_id": 921, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of a combination of isoflavones and berberine (ISB) in treating menopausal symptoms and dyslipidaemia.", "results_summary": "The ISB treatment significantly reduced plasma total cholesterol, LDL cholesterol, and triglycerides, and improved menopausal symptoms compared to the control group. Safety parameters remained unchanged during the study.", "population_specificity": "120 menopausal women with a mean age of 54.8 years and moderate dyslipidaemia.", "effective_dosage": "Not specified in the abstract.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:21.839074+00:00"}
{"study_id": 181198, "supplement_id": 921, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether a supplement containing berberine, along with other nutrients, could improve bone biomarker profiles in postmenopausal women with metabolic syndrome.", "results_summary": "The intervention group showed a significant 25% decrease in serum osteocalcin (indicating reduced bone turnover) and a 23% increase in serum 25-hydroxyvitamin D, while the placebo group had adverse changes. The supplement combination, including berberine, produced a favorable bone biomarker profile.", "population_specificity": "Postmenopausal women with metabolic syndrome", "effective_dosage": "100 mg berberine sulfate trihydrate twice daily", "study_duration": "14 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:24.708548+00:00"}
{"study_id": 49559, "supplement_id": 923, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of \u03b2-alanine supplementation on peak power, power drop, and lactate response in elite male amateur boxers.", "results_summary": "The study found that \u03b2-alanine supplementation significantly improved lower body peak power and helped maintain upper body power output compared to placebo, with moderate to large effect sizes. No significant effects were reported for lactate response.", "population_specificity": "Elite male amateur boxers from the Korean national team (n=19).", "effective_dosage": "4.9-5.4 g/day of \u03b2-alanine.", "study_duration": "10 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:25.444169+00:00"}
